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ABSTRACT 
MECHANICAL DEVELOPMENT AND FUNCTIONAL MECHANOSENSITIVITY DURING EARLY 
CARDIOGENESIS 
Stephanie Majkut 
Prof. Dennis E. Discher 
 
This thesis addresses the questions of when and how mechanical stiffness arises during 
embryonic heart development and how mechanics affects early cardiomyocyte and myocardium 
contractile function and cytoskeletal organization.  Previous studies addressing how mechanics 
influence the contractile and electrochemical capacity of mature cardiomyocytes on compliant 
substrates are reviewed in light of theory explaining how contractile striated fibers might optimally 
align on intermediate substrates.  Embryonic heart and brain tissue stiffness through early 
development are measured by micropipette aspiration, and the earliest functional heart is found 
to be three-fold stiffer than early embryonic tissue while brain remains soft.  Contraction strain in 
intact embryonic day 4 (E4)  heart tubes shows an optimum relative to hearts with softened or 
stiffened extracellular matrices.  Contraction wave velocity, however, goes linearly with softening 
or stiffening of tissue, consistent with a theory.  Isolated E4 cardiomyocytes cultured on collagen-
coated substrates of various stiffnesses show optimal contraction on substrates that match the 
stiffness of E4 tissue.  Sarcomere organization shows optimal organization in intact tissue relative 
to soft and on intermediate substrates relative to soft or very stiff.  The feedback between matrix 
stiffness and contractile capacity of cardiomyocytes in developing heart tissue is modeled and 
extended to include interactions with nuclear structural proteins, Lamins.  A method for perturbing 
and imaging nuclear lamina in vivo is discussed and preliminary measurements indicate that the 
nucleus could act as a measure for intracellular stresses.    
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PREFACE  
This thesis explores the influence of mechanics on the earliest functioning heart tissue from a soft 
matter physics perspective and introduces novel methods to study cardiomyocyte behavior in 
intact tissue.  The following summarizes each chapter:   
Chapter 1:  Cardiomyocytes from late embryos and neonates do optimal work and striate 
best on substrates with tissue-level elasticity: metrics and mathematics 
In this introductory chapter, we discuss recent studies on the mechanosensitive morphology and 
function of cardiomyocytes derived from embryos and neonates.  For early cardiomyocytes 
cultured on substrates of various stiffnesses, contractile function as measured by force 
production, work output and calcium handling is optimized when the culture substrate stiffness 
mimics that of the tissue from which the cells were obtained.  This optimal contractile function 
corresponds to changes in sarcomeric protein conformation and organization that promote 
contractile ability.   In light of current models for myofibillogenesis, a recent mathematical model 
of striation and alignment on elastic substrates helps to illuminate how substrate stiffness 
modulates early myofibril formation and organization.  During embryonic heart formation and 
maturation, cardiac tissue mechanics change dynamically.  Experiments and models highlighted 
here have important implications for understanding cardiomyocyte differentiation and function in 
development and perhaps in regeneration processes.   This review was published in 
Biomechanics and Modelling in Mechanobiology last year. 
Chapter 2:  Heart stiffening in early embryos parallels matrix and myosin levels to optimize 
beating.   
In development and differentiation, morphological changes often accompany mechanical changes 
[1], but it is unclear if or when cells in embryos sense tissue elasticity.  The earliest embryo is 
uniformly pliable, and although adult tissues vary widely in mechanics from soft brain and stiff 
heart to rigid bone [2], cell sensitivity to elasticity is debated [3].  Here we focus on embryonic 
 xi 
 
heart and isolated cardiomyocytes, which both beat spontaneously, with added motivations from 
regenerative medicine because rigid post-infarct regions limit pumping by the heart [4].  Tissue 
elasticity, Et, increases daily for heart to 1-2 kPa by embryonic day-4 (E4), and although this is 
~10-fold softer than adult heart, the beating contractions of E4-cardiomyocytes prove optimal at 
~Et,E4 both in vivo and in vitro.  Proteomics reveals daily increases in a small subset of proteins, 
namely collagen plus cardiac-specific excitation-contraction proteins.  Softening of the heart’s 
matrix with collagenase or stiffening it with enzymatic crosslinking suppresses beating strains in 
tens of minutes.  Sparsely cultured E4-cardiomyocytes on collagen-coated gels likewise show 
maximal contraction on matrices with native E4 stiffness, highlighting cell-intrinsic 
mechanosensitivity.  While an optimal elasticity for striation proves consistent with modeling of 
force-driven sarcomere registration, contraction wave-speed is linear in Et as theorized for 
Excitation-Contraction Coupled to Matrix Elasticity.  Mechanosensitive stem cell cardiogenesis 
helps generalize tissue results.  This chapter concludes with a brief discussion of the interplay 
between cardiomyocytes and cardiac fibroblasts that secrete matrix and thus establish tissue 
stiffness. 
Chapter 3:  Mathematical hypothesis on the interplay between Cardiomyocytes and 
Collagen-secreting Cardiac Fibroblasts in the developing heart   
As heart muscle stiffens due to deposition of collagenous extracellular matrix (ECM) by 
fibroblasts, cardiomyocytes must respond by increasing in contractile capacity through 
proliferation, growth and increased expression of sarcomeric proteins, which in turn influences 
fibroblast proliferation and ECM deposition.  Ultimately this feedback between the ECM and 
contractile elements of the heart come to a stable balance.  Here we review how fibroblast and 
collagen content evolves during heart development and suggest a model of how such a balance 
could be struck between myosin content and collagen content using the concept of tension 
stabilized biopolymers.  We also discuss how this model could be extended to include interplay 
with nuclear mechanics and conclude with a model capturing results of past experiments on 
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mechanosensitive structural proteins in the nucleus, the lamins, that can also influence 
expression of contractility genes..    
Chapter 4:  Method to visualize and study embryonic cardiomyocyte nuclei and Lamins in 
vitro and in vivo.   
This chapter outlines a method to visualize and perturb the lamina of individual nuclei within intact 
developing heart tissue and isolated cells on compliant substrates.  Sparse Lamin-A transfection 
of E4 chick heart tubes was performed before isolating the cells on collagen-coated 
polyacrylamide substrates.  We present and discuss preliminary data of nuclei strain relative to 
cell/matrix strain.   
Chapter 5:  Conclusions and future directions.   
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Chapter 1 : Cardiomyocytes from late embryos and neonates do optimal work and 
striate best on substrates with tissue-level elasticity – metrics and mathematics 
 
Published:  Majkut SF; Discher DE. (2012) Biomechanics and Modelling in Mechanobiology.  
11(8), 1219-1225.   
 
1-1: Introduction 
The rhythmic beating of cultured cardiomyocytes, like the rhythmic beating of the heart, provides 
a clear and simple signature of the central function of these cells.  Here we review recent single 
cell experiments and a mathematical model that have helped illuminate prominent effects of 
matrix elasticity on the function and structure of embryonic and neonatal cardiomyocytes.  The 
elasticity of culture substrates has been shown by several groups to impact beating forces and 
beating velocities as well as the calcium dynamics of isolated heart cells.  The effects extend, 
after many hours and thousands of beating cycles, to the expression and organization of the 
striated assembly of contractile proteins, even in dense co-cultures with cardiac fibroblasts.  This 
protein assembly occurs dynamically over minutes, and a recent mathematical model for 
alignment of striations not only exhibits similar dynamics but also a dependence on matrix 
elasticity. The measurements and modeling have significant implications for understanding 
differentiation during early heart development and are particularly important to factor into the 
many efforts to generate mature cardiomyocytes from stem cells. 
1-2:  Optimal Elasticity for Contraction and Calcium Excitation 
Is the heart a pump or an excitatory tissue?   It is both and more of course, but the fundamental 
function of the adult heart is to contract its internal volume in order to pump blood.  Moreover, the 
only way that a solid-walled tissue such as the heart can contract in volume is if the wall of the 
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heart is elastically deformable.  What has been less clear is whether the elasticity of the heart wall 
impacts the function of beating cardiomyocytes at the single cell level.  The issue is both 
important and timely because there are many groups that aim to generate – from embryonic stem 
cells, induced pluripotent stem cells, and cardiac stem cells , among others [5, 6, 7] – 
cardiomyocytes that will repair adult hearts after a heart attack or other injury.  Ultimately, heart is 
a muscle that does repetitive work on a load, and tissue elasticity Etissue at the scale of a cell is a 
significant part of that load in contributing to remodeling at a basic molecular level. 
Several recent studies have sought to physically quantify in culture the effects of matrix elasticity 
Em on late embryonic and neonatal cardiomyocytes.  Engler et al. (2008) [8] first made 
measurements of tissue elasticity Em with Atomic Force Microscopy (AFM) of chick heart at 
embryonic days 4, 7, 10 (E4,7,10), and then isolated cardiomyocytes from E7 embryos and 
characterized the morphological and functional effects of substrate stiffness on cells.  Collagen-I 
coated polyacrylamide gels provide a tunable matrix to which these embryonic cardiomyocytes 
attach firmly and beat spontaneously (Fig. 1-1A).  Beating of cardiomyocytes, which, as in the 
human heart, occurs at approximately 1 Hz, applies periodic strains to the matrix that can be 
estimated from the displacement of beads embedded near the gel surface.  The cells thus do an 
amount of work on the substrates that can be estimated by multiplying the square of the mean 
matrix strain under the cell, ϵout, by matrix elasticity, Em.  The estimated strains were relatively 
constant up to about the mean elasticity for heart of ~10 kPa as measured by AFM, and then the 
strains decrease at higher Em. The latter decrease reflects the fact that there must be some 
rigidity beyond which the cells simply cannot contract; it turns out that the limiting rigidity is close 
to the physiological tissue stiffness of ~10 kPa.  Work done on the substrate goes as Em ϵout
2
 
multiplied by a prefactor with units of volume that depends on the geometry of the system [9], and 
can thus be neglected.  Engler et al. (2008) [8] estimate this work as ½ Em ϵout
2
, which exhibits an 
optimum.  Below about 10 kPa, the cells do little work on soft matrix (low Em), and above about 
10 kPa, the cells cannot strain the stiff matrix (low ϵout).  As pointed out, rigid matrix also arises in 
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scarring after a myocardial infarction in adults, which is well known to impede contractile function 
of the heart.  Regardless, the optimal substrate stiffness aligns remarkably well with the micro-
elasticity measurements for E7 myocardium.   
Using a similar system of gel substrates, Jacot et al. (2008) [10] cultured neonatal rat ventricular 
myocytes (NRVM) and made careful measurements of both the rhythmic forces in beating as well 
as the much smaller ‘resting’ forces that are sustainably applied to a substrate due to a basal 
muscle tone in the cardiomyocytes (Fig. 1-1B).  NRVM do not beat spontaneously and need to 
be electro-stimulated, whereas the embryonic cardiomyocytes studied by Engler et al. (2008) [8] 
beat spontaneously.  Importantly, calcium spike dynamics measured by Jacot et al. (2008) [10] 
showed that 10 kPa matrix maximized both contractile force and the amplitude of calcium 
dynamics.  Excitation-Contraction Coupling (ECC) is a classic phenomenon in muscle physiology 
[11], and these results are consistent with ECC, but highlight the key role of matrix elasticity as a 
load on cardiomyocytes.   The results are clear for individual cells with no confounding impact of 
cell-to-cell electrical communication, which suggests that one needs to consider Excitation-
Contraction-Matrix Coupling (ECMC) in order to understand heart development and 
pathophysiology. 
Evidence in both studies above showed that the main protein motor in cardiomyocyte contraction, 
cardiac myosin, maintained a relatively constant level of expression.  However, Jacot et al. (2008) 
used a pharmacological inhibitor of the nonmuscle myosin pathway, namely a drug that blocks 
Rho-associated kinases (ROCKs), and the results showed that this inhibitor suppresses the 
decrease in force exerted by NRVM on stiff gels (Fig. 1-1B).  Such findings could lend insight into 
how and why the same drug protects against heart injury in animal models [12]. 
Co-cultures of NRVM and matrix-secreting fibroblasts derived from the same hearts were grown 
on PA gels for 5 days by Bhana et al. (2009) [13], who reported that – in their dense culture 
systems – cardiomyocyte function and cardiomyocyte numbers relative to fibroblasts appeared 
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optimal at substrate stiffness in the range of Em = 22-50 kPa (Fig. 1-1D).  The higher optimum in 
substrate stiffness is thought to match the mechanics of adult rat cardiac tissue, which the same 
group measured by a pipette aspiration method.  It should be noted that cardiomyocytes beat 
synchronously when in direct contact with each other.  Synchronously beating cardiomyocyte 
aggregates produce more force than individual cells [14], which may explain why these cells 
functioned so well on somewhat stiffer substrates than in the other studies and the neonatal 
tissue from which they were derived.  
Bajaj et al (2010) [15] looked at similar dense co-cultures of E8 chick-derived cardiomyocytes and 
fibroblasts on PA gels of 1, 18, and 50 kPa and on tissue culture plates for 1-5 days.  They found 
that the cells initially beat with frequencies modulated by substrate stiffness, with the fastest 
beating on the 18 kPa.  However, after 5 days, as the cells proliferated and came into contact 
with each other, the beat frequencies became more uniform within each culture and across 
culture conditions, and the fastest beating occurred in the 50 kPa gel cultures. This is likely due to 
the cells in contact with each other beating in synchrony.  Immunofluorescent imaging of focal 
adhesion (FA) formation and growth in the different culture conditions revealed increased FA area 
and number on stiff substrates over time and decreased FA area and number on the softest gels 
over time. Interestingly, this decrease in FA number and size corresponds to a less organized 
sarcomeric cytoskeleton on soft substrates relative to the well developed and aligned myofibrils 
observed on stiff substrates.   
Using a very different type of substrate, Rodriguez et al. (2011) [16] cultured NRVM on fibronectin 
coated elastic micropilli arrays with effective shear moduli estimated to range from 3-20 kPa.  The 
twitch force, work, and power generated by single cells once again increased with substrate 
stiffness (Fig. 1-1C). In addition, calcium activity increased in the NRVM on stiffer substrates.  
The authors also made direct comparisons of forces produced by neonatal myofibrils to adult 
myofibrils, showing that neonatal myofibrils generate only about one-third the power of adult 
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myofibrils.   The results underscore the importance of developmental stage and age of the cells 
studied.  
In addition to functional characterizations of the effects of substrate mechanics on force and work 
output of cardiomyocytes, several of the studies above also attempted to uncover some of the 
molecular changes that underlie measurable functional changes.  Engler et al. (2008) [8] imaged 
alpha-actinin and noted that 1 day cultures on ~10 kPa matrix exhibited a maximum fraction of 
cells with sarcomeric striations.   They also applied a novel method of labeling proteins within 
cells to expose differences in molecular structure or activity (Cysteine Shotgun Mass 
Spectrometry; [17]), and the analysis indeed identified substrate-stiffness dependent differences 
in myosin and other cytoskeletal proteins as well as one metabolic protein, the muscle-specific 
pyruvate kinase M1.  The latter is intriguing because the studies of ROCK inhibition of the heart 
cited above also identified drug-dependent difference in several metabolic proteins [18].   On the 
other hand, such results are very sensible because differential force-generation by muscle places 
differential demands on metabolism.  Moreover, in the drug studies of Jacot et al. (2008) [10], 
imaging of alpha-actinin in untreated cells revealed a tendency for reorganization of striated 
sarcomeres into stress fibers, whereas drug treatment blocked this reorganization.  As mentioned 
above, Bajaj et al. (2010) [15] noted that disorganized and unaligned myofibrils in cardiomyocytes 
grown on soft substrates corresponds to decreased FA area and number relative to the those of 
cells grown on stiffer substrates, which had well aligned myofibrils.  Rodriguez et al. (2011) [16] 
quantified the striations of cardiomyocytes on their microposts through measurements of 
sarcomere spacing and z-disk width.  They reported that sarcomere spacing, a sign of myofibril 
maturity and an indicator of likely force output, fell within accepted values for mature myofibrils on 
all substrates, and increased with increasing stiffness.  Z-disk breadth, which indicates increased 
coupling of sarcomeres within a myofibril, also increased with E.  Increased sarcomere spacing is 
associated with increased force production because it allows for a greater number of cross-
bridges to form during contraction.  Increased z-disk breadth, in turn, maintains registry of 
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sarcomeres within a myofibril, minimizing myofibril buckling during contraction and maximizing 
contraction velocity.   
1-3:  Matrix Elasticity and Sarcomere Organization  
If organizational and structural changes in cytoskeletal structure underlie the functional, 
mechanical outputs of the cardiomyocytes, how might substrate mechanics modulate this 
organization?  Cardiomyocytes sense and respond to intra- and extracellular mechanical stimuli 
through a variety of molecular mechanisms; integrins in costameres and focal adhesions transmit 
loads from the ECM to the cytoskeleton, cadherins connect myofibrils between cells at adherens 
junctions, and sarcomere-spanning proteins such as titin respond to intracellular stresses 
(reviewed in [19]).  In considering what types of mechanisms may modulate myofibril organization 
as observed in the studies above, it is useful to consider how myofibrils form.  Sanger et al. 
(2005) [20] proposed at least one pathway by which myofibillogenesis occurs in striated muscle 
cells, and the process begins at the cell membrane, adjacent to matrix, with stress-fiber-like 
periodic premyofibrils.  These progressively register with each other and mature into myofibrils 
through replacement of short filaments of nonmuscle myosin-IIB (NMMIIB) by long filaments of 
muscle myosin-II plus incorporation of other sarcomeric proteins (Fig. 1-2A).  Premyofibril 
formation, registration, and maturation into mature myofibrils have been visualized in live 
spreading cardiomyocytes in culture (Fig. 1-2B), in precardiac explants, and also in whole 
embryonic hearts [21].  These studies were performed in a variety of vertebrate organisms; quail, 
chick, and zebrafish.  However, this model is not universally accepted due to possible conflicting 
evidence from, for example, experiments in which NMMIIB knock-out mice still develop mature 
myofibrils.  Sanger et al (2010) [21] argue that such evidence does not preclude their model 
because other NMMII isoforms might be upregulated or otherwise compensate for the loss of 
NMMIIB.  Other mechanisms of myofibrillogenesis have been proposed, such as a self-templating 
model in which free actin and myosin filaments incorporate into preexisting myofibrils [22, 23, 20]. 
These different mechanisms may occur to different degrees in various circumstances and 
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different species, possibly explaining some of the observations contradicting the Sanger’s 
premyofibril model.  However, it does seem clear the premyofibril pathway to myofibrillogenesis is 
a prevalent if not a unique pathway.   
Since premyofibrils form close to the surface of the cell, this first step of myofibril formation is a 
likely target of the substrate-stiffness modulation that leads to the variation in sarcomeric 
organization observed in the experiments above.  Friedrich et al. (2011) [24] therefore proposed a 
general physical theory for how striated contractile fibers interactions with an elastic substrate 
could promote interfiber registry (Fig. 1-2C).  They modeled the force transmitted by a fiber to the 
substrate as a periodic linear array of force dipoles, and the substrate as an elastic half space 
with a matrix elastic modulus, Em, and a Poisson ratio,  .  For two such fibers aligned parallel to 
each other, the elastic interaction energy between was derived as 
               
 
 
   
  
 
   
    
    
 
              (1-1) 
Here,   is the sarcomeric periodicity of each fiber,   is the distance between the fibers, and    is 
the phase shift between the two fibers, (Fig. 1-2C-i).   (
 
 
  ) describes the lateral propagation of 
the strain field produced by a single fiber.  For simplicity, the dipole density was approximated as 
the first Fourier mode              (
   
 
),  so    is the amplitude of the dipole density.  When 
  
 
 
, as is the case for the polyacrylamide substrates of the experiments discussed previously 
and 
 
 
          (
 
 
 
 
 
)   .  This indicates that neighboring fibers should be inclined to come 
into registry such that      .   
The registration force on one fiber due to this elastic interaction with its neighbor is      
 
             
   
.  Friedrich et al. (2011) [24] used this relation to model the overdamped sliding of 
fibers relative to each other, where the net force on the fibers is the sum of the interaction force 
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and a stochastic noise term.  They further consider the experimental observations of substrate 
stiffness strengthening cell-substrate adhesions and active cell contractility.  They model these 
effects as     
  
   
     
 .  This gives a maximal registration force that is a nonmonotonic function of 
Em  
      
  
 
  
  
  
      
   
                                            (1-2) 
and is modulated by an optimal   
 .  Using this registration force, they simulated the sliding 
dynamics of an array of n = 10 fibers over a range of Em .  To quantify the degree of interfiber 
registration, they defined the smectic order parameter for the resulting configurations 
  ∑     
  
 
      
   
                                            (1-3) 
The ensemble average of this order parameter, <S>, as a function of matrix elasticity is plotted for 
various times in Fig. 1-2C-iii.  The resulting curves are fit with the same functional form as the 
registration force Eq. 1-2 and exhibit an optimum in matrix elasticity at ~10 kPa. Therefore, elastic 
coupling between adjacent myofibrils can give rise to organizational trends much like those 
observed in the studies discussed above.  Additionally, organizational dynamics predicted by this 
model occur on timescales of minutes to hours, which is thousands of cycles of rhythmic beating 
of cells.   
A strong separation of time scales seems consistent with the slow re-organization of sarcomeres 
as a function of Em as reported in the experimental studies above of Engler et al. (2008), Jacot et 
al. (2008), and Rodriguez et al. (2011).   Thus, the clearest clock in the cell, its beating frequency, 
is not strictly coupled to formation or disruption of the central structure-function relationship in 
muscle, namely the contractile sarcomere.  In materials science, processes such as work-
hardening, which improves strength, and cyclic fatigue or failure, which compromise application, 
seem related to the force-dependent striation processes in muscle.  The relation suggests the 
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importance of dislocations, defects, and cracks in heart development and disease, motivating 
further quantitative measures and mathematical models.  
 1-4:  Microenvironment of Early Cardiomyocytes 
It is important to note that in the developmental stages of the cardiomyocytes used in the studies 
above, the heart is a well-differentiated, 4-chambered organ with a substantial extracellular 
matrix.  Although further growth and stiffening of cardiac tissue with development and aging 
occurs [13, 25], such mature tissue is already much stiffer at ~10 kPa than the earliest beating 
heart stages that have approximate elastic moduli of ~0.5-2 kPa [26, 27, 28].  Early embryonic 
cardiac tissue is very fragile, heterogeneous, and small.  It is also only slightly stiffer than early 
embryonic tissue, which is typically measured to have Etissue in the range of 0.1- 1 kPa [29, 27, 
30].  Since the heart is the first functional organ to develop in the vertebrate embryo, initial 
myofibril formation, which shortly precedes the first heart beats, occurs much earlier in 
development than the stages from which the cells in studies cited here are derived.  As a result, 
the impact of mechanical microenvironment on the earliest cardiomyocytes is less well less 
defined.   
1-5: Conclusion 
Given that cardiac mechanics develop progressively in an embryo, an important set of 
developmental questions emerges from the findings reviewed here that relatively well-developed 
cardiomyocytes “beat best” on matrices that mimic the mechanics of the original, mature tissues.  
A first key question is when do cardiomyocytes in the earliest embryo begin to respond to the 
micro-elasticity of the tissue?   Do defects in striation emerge or are they avoided?  Do such 
processes trigger new gene programs in development to promote (or undermine) robustness in 
structure-function?  The experimental analyses and mathematical modeling summarized briefly 
here offer new tools to apply to such questions, and they are especially relevant to the current 
work with stem cells that may one day allow repair of adult heart tissue. 
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Figure 1-1: Isolated cardiomyocytes plated on gels of various stiffnesses. (A) Engler 
et al. (2008) [8] characterized the morphological and functional effects of substrate stiffness on 
embryonic cardiomyocytes isolated from E7 chick embryos cultured on collagen-I-coated 
Polyacrylamide (PA) gels.  They found that the cells put out the most work on substrates of ~10 
kPa.  This optimal substrate stiffness matches that of E7 myocardium as they measured by AFM.  
(B) Jacot et al. (2008) [10] cultured at neonatal rat ventricular myocytes (NRVM) on PA gels of 1 
kPa, 10 kPa, and 50 kPa. They found that 10 kPa optimized NRVM function measured by 
contractile force generation and calcium activity.  Furthermore, inhibition of ROCK and RhoA 
pathways eliminate the decreased force production of NRVM on stiff gels.  (C) Rodriguez et al. 
(2011) [16] cultured NRVM on fibronectin-coated microposts with an narrow range of effective 
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moduli ranging from 3-20 kPa and found that twitch force, work, and power increased with 
substrate stiffness.  In addition, calcium activity increased in NRVM on stiffer substrates.  (D) 
Bhana et al. (2009) [13] co-cultured both NRVM and fibroblasts isolated from the same tissue on 
PA gels for 5 days, and monitored not just NRVM morphology and function, but the relative 
population changes of fibroblasts and cardiomyocytes.  They found that cardiomyocyte function 
and population relative to fibroblasts were optimal at substrate stiffness of 22-50 kPa relative to 
soft (3 kPa) and stiff (144 kPa).
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Figure 1-2: Myofibril formation and registration modulation by substrate stiffness. (A) 
Premyofibril model for myofibril formation (Sanger et al. 2005) [20]. Striated premyofibrils 
comprised of alpha-actinin-enriched z-bodies, short actin thin filaments and nonmuscle myosin 
IIB filaments mature into mature myofibrils by replacement of nonmuscle myosin II with muscle 
myosin II and incorporation of other sarcomeric proteins. (B) Premyofibril formation, registration, 
and maturation into mature myofibrils have been visualized in live spreading cardiomyocytes, as 
shown (Sanger et al. 2005) [20], in precardiac explants, and in whole embryonic hearts (Sanger 
et al. 2010) [21]. White arrows indicate premoyfibrils deposited near the edge of the spreading 
cell.  (C) Theoretical model proposed by Friedrich et al. (2011) [24] showing how aligned striated 
fibers on elastic substrates may come into registry in a substrate-stiffness dependent manner.  (i) 
Striated fibers apply stresses at the cell-substrate interface that can be modeled as periodic line 
of force dipoles. (ii) Adjacent fibers interact through the laterally propagating strain fields they 
produce.  (iii) These interactions lead fibers to come into registry with each other in a 
nonmonotonic substrate-elasticity-dependent way.  The smectic order S of the resulting arrays of 
striations is a measure of the level of registration.  
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Chapter 2:  Heart stiffening in early embryos parallels matrix and myosin levels to 
optimize beating 
 
In Press:  Majkut SF, Idema T, Swift J, Krieger C, Liu A, Discher DE. (2013) Current Biology.   
 
Mass-Spec and analysis performed by Dr. Joseph Swift.  Latrunctulin recovery assay’s performed 
by Dr. Christine Krieger.  Modeling of contractile wave propagation and theory performed by Dr. 
Timon Idema with Prof. Dr. Andrea Liu. 
 2-1: IntroductionThe heart is the first functional organ in vertebrate embryos, beating 
spontaneously as a tube by ~36 hr post fertilization (Fig. 2-1A).  Subsequent stiffening has been 
described thusfar in terms of changes in cell volume, hyaluironic acid, and/or collagen-I [31] – but 
functional tests are lacking.  Cardiomyocytes isolated from either late embryos [8, 32] or neonates 
[10, 16, 33]and cultured on substrates of varied stiffness suggest that gels which are stiffer than 
adult heart suppress contraction.  Extremely soft substrates suppress sarcomere organization 
and limit contractile ability, with additional evidence of altered cytoskeletal conformation and 
assembly [8] in the absence of changes evident in other cells such as mechanosensitive 
degradation [34] or transcription [35].  Mature cells cultured on gels can thus exhibit an optimal 
stiffness for contraction, but the relevance to intact heart is unclear.    
2-2: Results and Discussion 
Heart stiffens with expression of Excitation/Contraction/Collagen proteins, while Brain 
remains soft 
Tissue aspiration into micropipettes (Fig. 2-1B) of diameter sufficient to probe dozens of cells [1] 
shows that heart at all stages behaves elastically (Fig. 2-1C) whereas midbrain tissue and 
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embryonic disk flow over minutes and fail to recover fully after release of the stress.  The effective 
Young’s modulus of each tissue, Et, was calculated from the slope of aspiration pressure versus 
aspirated length (Fig. 2-S1A) [36], and for brain and embryonic disc, the (already large) aspirated 
length at 2 min was used.   By E2, the presumptive ventricle is already 3-fold stiffer than 
undifferentiated embryonic disc and embryonic brain.  The latter remains roughly constant 
through development at 0.3 ±0.2 kPa (Fig. 2-1C), consistent with adult brain [37].  Thus brain 
tissue is always soft whereas heart stiffens up to about 10-fold to reach neonate and adult heart 
stiffness by E14 [8].  Modest stiffness variations of ±20% along the developing heart tube (Fig. 2-
S1B) are also consistent with previous measurements [28].  
Expression trends of at least some tissue proteins seemed likely to parallel the trends in tissue 
mechanics and to confer tissue stiffness.  Quantitative mass spectrometry of extracts from 
embryonic discs, and E2-E4, and E10 heart and brain tissue identified over 200 diverse proteins 
(Table S1), of which fewer than 10% followed trends in expression similar to those of Et (Fig. 2-
1D-G, 2- S1C-D).  Most trend-following proteins related closely to the excitation-contraction 
coupling system such as cardiac actomyosin contractile proteins, adhesion proteins, and the 
SERCA channel.  Proteins that were notably not correlated with tissue stiffness included many 
nuclear proteins, intermediate filament proteins, and nonmuscle myosin.  It should also be noted 
that this proteomic-focused analysis neglects other particularly important early embryonic heart 
tissue ECM components, such as Hyaluronic acid(HA).  Changes in levels of HA, for instance 
could affect cell behavior, organization and development of these early cardiomyocytes outside of 
the mechanical changes of the surrounding tissue [38].  HA is also notably a prominent ECM 
component of adult brain.  Of two ECM proteins detected, only collagen-I follows the Et trends.    
To begin to assess stiffness contributions of the actomyosin cytoskeleton or collagen, we 
inhibited myosin contractility with the myosin-II ATPase inhibitor blebbistatin or else disrupted the 
collagenous ECM with mild collagenase treatments, and then measured tissue stiffness.  With 
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blebbistatin, heart tissue from E2 to E14 is softened by ~25% and brain tissue by ~50% (Fig. 2-
S1E).  In contrast, collagenase had no significant effect on brain tissue but considerably softened 
both early and late heart (Fig. 2-S1F) – without perturbing myosin-II levels (Fig. 2-S1G).  The 
stiffness of brain tissue thus seems cellular in nature, whereas heart tissue mechanics have 
major extracellular matrix contributions at even the earliest functional beating stage.   
 
Optimal elasticity of embryonic heart:  modest softening or stiffening impairs beating at E4  
Embryonic heart tubes beat spontaneously at ~1 Hz for up to 1-2 days after isolation, and we 
could easily measure local tissue strain heart tubes during beating by imaging GFP transfected 
cells as fiducial markers (Fig. 2-2A).  This very visible activity is used to address the main 
question of our studies:  whether cells in an intact living tissue are sensitive to microenvironment 
elasticity.  Controlled dose-time treatments with collagenase provided a simple means of 
softening  tissue matrix (in just 30 min), while enzymatic crosslinking of ECM with 
transglutaminase provided a method to stiffen tissue (Fig. 2-S2A,B).  Enzyme permeated the 
tissue (Fig. 2-S2C), and for all but the most extreme softening treatment, embryonic heart 
behaved elastically in micropipette aspiration (Fig. 2-S2B-inset).  By transfecting cells with a 
GFP membrane protein (SIRPA-GFP) we could also see that the contours of beating cells were 
unaffected by collagenase (Fig. 2-2B, 2-S2D), and so tissue softening is due primarily to 
cleavage of ECM rather than disruption of cell connections.   
After the enzymatic treatments, hearts continue to beat rhythmically (Movies 2-S1), but the 
magnitude of local contraction (calculated from GFP expressing cells) was always affected.  Each 
heart tube region was analyzed separately (Fig. 2-S2E-I), and normalization to pre-treatment 
measurements accounted for slight variations (~20%) in embryo age and/or lab temperature.  
Untreated tissue invariably showed the largest contraction, which was typically ~10% strain, while 
both softening and stiffening of the heart suppressed contractile strain (Fig. 2-2C, 2-S2E).  
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Stiffening of tissue should suppress strain since any muscle cell has a finite capacity to work 
against a very high load, but softening of the tissue matrix also decreased contractile strain.  
Consistent with these E4 results, softening of E6 hearts likewise impeded beating (Fig. 2-2D).  A 
mathematical theory for striation [39] provided a basis for modeling contractile function (Box 2-1) 
and fits the experiments (Fig. 2-2C, dashed line). The optimal stiffness for heart contraction is 
thus the stiffness of native heart.   
The speed of the contraction wave in each heart region increases monotonically with tissue 
stiffness, except for the most extreme rigidity (Fig. 2-2E). The linearity of wave speed can be 
predicted from a viscoelastic model of active media (Box 2-2).  For the rigidified heart, beating 
was still evident, but the contraction wave did not propagate past the pacemaker region in the 
atrium (Fig. 2-S2I).  Softening treatments also decreased the probability of contractions 
propagating out of the atrium.   
 
E4 and stem cell derived cardiomyocytes are highly sensitive to matrix elasticity  
To assess whether variations in matrix elasticity affect E4-cardiomyocyte adhesion and beating, 
isolated cells and their properties were studied as sparse cultures on collagen-I coated 
polyacrylamide gels of varied stiffness (Fig. 2-3A).  Most of the cultured cells beat at 0.5-1.5 Hz, 
similar to the heart, indicating high viability as well as sustained adhesion.  Relaxed morphologies 
were measured after 24 hr in culture and showed that substrates stiffer than E4 heart tissue 
promote spreading and elongation (Fig. 2-S3A), as is common with other mesenchymal cell 
types (e.g. [35]).  Cells on matrices of stiffness similar to that of the tissue of origin (~1-2 kPa) 
were relatively round and unspread compared to the maximum achievable elongation and 
spreading.   Nonetheless, contractile deformation of an E4 cardiomyocyte and its local matrix 
proves optimal at the matrix elasticity of native E4 tissue (Fig. 2-3B).  In vitro contractions were 
measured in terms of both 2D strains using cell edge displacements and changes in aspect ratio. 
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Cardiomyocytes derived from embryonic stem cells (ESC-CM), induced pluripotent stem cells 
(iPS-CM) or directly transdifferentiated cells hold great potential for regenerative therapies [40], 
and human ESC-CM and iPS-CM displace soft matrix more than stiffer matrix [41].  Here, ESC-
CM on soft, intermediate and stiff substrates that match immature (1 kPa), mature (11 kPa), and 
diseased (34 kPa) myocardium express at day-4 in culture similar levels of sarcomeric proteins 
but myofibril organization is visibly optimal for intermediate stiffness and contracting edge-
velocities decrease with substrate stiffness (Fig. 2-S3B-E).  On soft substrates in day-6 cultures, 
myofibrils decrease and beating stops, while ESC-CM on the intermediate and stiff substrates 
bifurcated into either fast or slow contracting cell populations.  Cardiogenesis is thus 
mechanosensitive to matrix.    
 
Optimal striation depends on Myosin-II contractile activity  
Organization of the actomyosin cytoskeleton into sarcomeres and myofibrils within striated 
muscle cells is a well-established determinant of contractile activity [8, 10, 16], but in living 
zebrafish, fluorescence recovery after photobleaching shows striation proteins are mobile on 
timescales of 1-10 min [42].  Cardiomyocytes treated with the myosin-II ATPase inhibitor 
blebbistatin do not beat even though calcium transients are unaffected [43], and cells beat again 
within seconds after drug washout [44].  This is far quicker than contractility responses to heart 
matrix alterations in the 0.5-2 hr treatments here. To assess a role for myosin-II activity and 
contractile forces in striation as assumed in the modeling here [45] (Box 2-1), E7 cells with 
abundant striation were grown on gels optimal for striation [8], pulsed for 30 min with latrunculin 
to disassemble myofibrils, and then blebbistatin was added to half of the cultures (Fig. 2-3C,D).  
In the absence of blebbistatin, both premyofibrils and mature myofibrils recovered over a few 
hours from the induced disassembly, and most cells were filled with striations after 24 hr (Fig. 2-
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3D,E), whereas sustained blebbistatin suppressed striation, consistent with striation requiring 
active myosin-II.   
 
Myofibril order depends on matrix elasticity in vivo and in vitro     
With E4 hearts, we sought to quantify any possible striation differences with and without matrix 
alterations.  Sarcomeric α-actinin-2 is a key crosslinker of ‘z-discs’ that is seen in mature 
myofibrils within embryos and also in shorter period premyofibrils using deconvolution microscopy 
[46].  In our confocal imaging, we measured sarcomere spacing lateral ‘breadth’ of z-discs along 
in-plane sarcomeres as a key metric of registry (Fig. 2-4A-inset).  Whereas striation spacing 
peaked at 1.8 μm and appeared unaffected by ~50% softening of the E4 heart, the z-disc breadth 
was reduced relative to untreated control (Fig. 2-4B).  This decreased registry of myofibrils 
shortly after softening of the matrix indicates a decreased coupling of sarcomeres and is 
consistent with the striation model [45], highlighting a molecular-scale mechanism for decreased 
contraction against decreased extracellular load.   
 Isolated cardiomyocytes beating on gels (Fig. 2-4C) show striation spacing of ~1 μm for 
premyofibrils, which conforms to expectations [42], and also the typical ~1.9 μm spacing of 
myofibrils (Fig. 2-4D) evident in intact heart.  Striation spacing shows no variation with matrix, but 
the abundance of myofibrils relative to premyofibrils is maximized on matrices of elasticity 2-10 
kPa (Fig. 2-4E). This is consistent with myofibril assembly from premyofibrils [42].  The z-disc 
breadth of myofibrils also exhibited a broad and significant (p < 0.05) maximum (at ~2 μm 
breadth) within a similar range of matrix elasticities that promote myofibril formation (Fig. 2-4F).  
The premyobrils exhibited a somewhat narrower (~1.5 μm) z-disc breadth that at least decreased 
on the stiffest substrates.  Myofibril structural trends in response to substrate stiffness in culture 
are thus consistent with intact E4 heart and suggest a common mechanism of stiffness-
dependent registration.   
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 Z-disc breadth results for both mature myofibrils and premyofibrils (Fig. 2-4F) were also 
fit by the peaked function of Box 1 with respective Em = 4.2±0.6 and 1.7±0.3 kPa (n = 0.24 ±0.1).  
Differences in Em suggest myofibril organization favors a stiffer matrix or higher load.  However, 
z-disc breadth also likely underestimates registration order within a cell, as it only includes 
immediately adjacent and perfectly registered striated fibers.  Indeed, z-disc breadth trends for 
myofibrils and premyofibrils in isolated cells are broader than in simulation [45] but still consistent 
with trends for intact heart (Fig. 2-4B,F).  What emerges systematically from fitting to Eq. 1 is that 
n increases with length scale:  the smallest n is determined for z-disc breadth in culture and the 
largest n is found for strain in the intact heart.  High cell density, 3D cell-matrix coupling, and cell-
cell signaling in tissue (including calcium excitation waves) could all provide a basis for the 
enhanced sensitivity to matrix E of tissue. 
Protein interactions that govern molecular mobility are force sensitive in living cardiomyocytes 
and vary with matrix elasticity [8].  An optimum stiffness for striation is thus understandable:  while 
contractile activity ‘massages’ registration (Fig. 2-3E, 2-4) and these forces increase with matrix 
stiffness [1], high forces on stiff matrix tend to break bonds [8].  Myofibrils thereby mis-register if 
the load is either too low or high, which largely explains why parallel and optimal increases in 
actomyosin proteins and collagens (Fig. 2-1) must be coordinated in the tissue development 
program.  Invading and proliferating fibroblasts make and remodel the matrix that stimulates 
cardiomyocyte proliferation [47] with increased expression of specialized contractile proteins (α-
actinin-2, cardiac myosin-II in Fig. 2-1D,E), and so it is sensible that this program requires matrix 
engagement by integrins [47] and extends to mechanosensitive, adhesion complex proteins such 
as talin [48] that also increase (Fig. 2-1D).  Moreover, since collagen synthesis and organization 
by fibroblasts is regulated by strain (as reviewed in [49]), heart matrix is likely to be optimized by 
the optimal stiffness for cardiomyocyte striation and contraction (Fig. 2-4).  The fact that the 
optimum shifts in development from 1-2 kPa at E4 and at E7 toward the stiffness of adult heart 
(eg. Fig. 2-1C, 2-3E inset) [8, 10, 16] is also consistent with initial observations that hearts which 
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were stiffened and stop beating are found to re-start their beating ten hours later. Lastly, 
Excitation–Contraction Coupling (ECC) in muscle physiology is well-established [11], but the 
broad effects of matrix stiffness on individual cells and structures even in sparse culture preclude 
the confounding impacts of cell-cell electrical communication and suggest that Excitation–
Contraction–Matrix Coupling (ECMC) is required to truly understand muscle.   
 
2-3: Experimental Procedures  
Heart isolation, enzyme treatments, micropipette analyses, tissue strain analyses, mass 
spectrometry proteomics, cell isolation, and the standard techniques are described in detail in the 
following subsections.  
Tissue isolation   
White Leghorn chicken eggs (Charles River Laboratories) were incubated at 37˚C, rotated once 
per day, until the desired developmental stage was reached.  Embryos were extracted at room 
temperature by windowing eggs, removing extraembryonic membranes with forceps and cutting 
major blood vessels to the embryonic disc tissue to free the embryo.  The embryo was placed in a 
dish containing PBS and quickly decapitated.  For E2-E5 embryos, whole heart tubes were 
extracted by severing the conotruncus and sino venosus.  For older embryos, whole hearts were 
extracted by severing the aortic and pulmonary vessels and the pericardium was sliced and  
teased away from the ventricle using extra-fine forceps .  Brain tissue was collected from the 
presumptive midbrain. Embryonic discs were removed by windowing the egg, cutting out the 
embryo with the overlying vitelline membrane intact, lifting out the embryo adherent to the vitelline 
membrane and placing in a dish of PBS.  Extraembryonic tissue was carefully cut away using 
dissection scissors and the finally embryo was teased away from the vitelline membrane using 
forceps.  All tissues were incubated at 37˚C in pre-warmed chick heart media (alpha-MEM 
supplemented with 10 % FBS and 1% penn-strep, Gibco, 12571-063) until ready for use.   
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Mass-Spectrometry of tissues 
For proteomic studies, tissue of interest was washed three times by successive resuspension in 
ice-cold PBS and diced to sub-millimeter pieces. Proteins were solubilized by cellular disruption 
with a probe sonicator in ice-cold RIPA buffer with 0.1% protease inhibitor cocktail (approx. 5000 
cells / μL). NuPage LDS sample buffer (Invitrogen) with 1% β-mercaptoethanol was added to 1x 
concentration, followed by heating to 80°C for 10 min. Proteins were separated on SDS-PAGE 
gels (NuPAGE 4-12% Bis-Tris, Invitrogen), run at 100 V for 10 min followed by 25 min at 160 V. 
Sections of excised polyacrylamide gel (cut in two molecular weight ranges: 55-100 kDa and 100-
300 kDa) were washed (50% 0.2 M ammonium bicarbomate (AB) solution, 50% acetonitrile, 30 
min at 37 °C), dried by lyophilization, incubated with a reducing agent (20 mM tris(2-
carboxyethyl)phosphine in 25 mM AB solution at pH 8.0, 15 min at 37°C) and alkylated (40 mM 
iodoacetamide in 25 mM AB solution at pH 8.0, 30 min at 37 °C). The gel sections were dried by 
lyophilization before in-gel trypsinization (20 μg/mL sequencing grade modified trypsin in buffer 
as described in the manufacturer’s protocol (Promega Corp. Madison, WI), 18 hr at 37°C with 
gentle shaking). Before analysis, peptide solutions were acidified by addition of 50% digest 
dilution buffer (60 mM AB solution with 3% methanoic acid). 
Peptide separations (5 µL injection volume) were performed on 15-cm PicoFrit column (75 µm 
inner diameter, New Objective) packed with Magic 5 µm C18 reversed-phase resin (Michrom 
Bioresources) using a nanoflow high-pressure liquid chromatography system (Eksigent 
Technologies), which was coupled online to a hybrid LTQ-Orbitrap XL mass spectrometer 
(Thermo Fisher Scientific) via a nanoelectrospray ion source.  Chromatography was performed 
with Solvent A (Milli-Q water with 0.1% formic acid) and Solvent B (acetonitrile with 0.1% formic 
acid).  Peptides were eluted at 200 nL/min for 3–28% B over 42 min, 28–50% B over 26 min, 50–
80% B over 5 min, 80% B for 4.5 min before returning to 3% B over 0.5 min. To minimize sample 
carryover, a fast blank gradient was run between each sample.  The LTQ-Orbitrap XL operated in 
the data-dependent mode to automatically switch between full scan MS (m/z = 350-2000 in the 
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orbitrap analyzer with resolution of 60,000 at m/z 400) and fragmentation of the six most intense 
ions by collision-induced dissociation in the ion trap mass analyzer. 
 Raw mass spectroscopy data was processed using Elucidator (version 3.3, Rosetta 
Biosoftware, Cambridge, MA). The software was set up to align peaks in data from samples 
derived from the same ranges of molecular weight. Peptide and protein annotations were made 
using SEQUEST (Thermo Fisher Scientific) with full tryptic digestion and up to 2 missed cleavage 
sites. Peptide masses were selected between 800 and 4500 amu with peptide mass tolerance of 
1.1 amu and fragment ion mass tolerance of 1.0 amu. Peptides were searched against a 
database compiled from UniRef100 human (for proteomic studies, downloaded 05-Nov-2010) or 
UniRef100 gallus gallus (for matrix studies, downloaded 12-Jan-2011), plus contaminants and a 
reverse decoy database. Search results were selected with a deltaCn filter of 0.01 and mass error 
better than 20 ppm. Ion currents of oxidized peptides (Δ = +15.995 Da) were summed with their 
parent peptide; post-translational modifications of phosphorylation (Δ = +79.966 Da), acetylation 
(Δ = +42.011 Da) and methylation (Δ = +14.016 Da) were entered in the search. In matrix studies, 
we additionally looked for hydroxylation of proline, asparagine, aspartic acid, and lysine (Δ = 
+15.995 Da).  
The two MW ranges of the proteomic dataset were analyzed separately. In the mid-MW range 
(55-100 kDa), the false-positive (FP) detection rate was estimated to be 11.4% (based on search 
hits of the decoy database) and only proteins with two-or-more peptides/protein were considered 
for further analysis (2015 peptides from 231 unique proteins). High-MW range (100-300 kDa): FP 
rate = 11.3%; subsequent analysis of 1223 peptides from 55 unique proteins. Label free relative 
peptide quantitation was performed with in-house software coded for Mathematica (Wolfram 
Research, Champaign, IL). Datasets were normalized against optimized housekeeping peptide 
sets that were found to be invariant between experimental conditions. A peptide-set optimization 
algorithm (PRF, [50]) was used to select peptides that show a similar ‘fingerprint’ behavior 
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between samples, and these peptides were used for the basis of quantification and normalization. 
We report only quantification of proteins with at least three PRF peptides/protein (total 178 
proteins). Peptides from regions common to several proteins or isoforms were treated distinctly. 
Standard errors were calculated from at least 2 technical repetitions. As a further check of the 
peptide selection algorithm, ratio comparisons were made between all datasets and checked for 
consistency (for example, when considering data A, B and C, the ratio A:B should be consistent 
with A:C x C:B). 
 
Sample preparation, gel electrophoresis and immunoblotting.    
Frozen whole embryo (Hamburger-hamilton stage 5-8, n = 4) and tissue from E4, E6, and E14 
chick heart (n = 4, 2, and 1, respectively) and brain (n = 3, 2, and 1, respectively) diced to 
approximately 10 mm³, was suspended in ice-cold 1x NuPAGE LDS buffer (Invitrogen; 1% 
protease inhibitor cocktail, 1% β-mercaptoethanol) and subjected to sonication on ice (3 x 15 x 1s 
pulses, intermediate power setting). Samples were then heated to 80 °C for 10 min and 
centrifuged at maximum speed for 10 min. SDS-PAGE gels were loaded with 5 – 15 μL of lysate 
per lane (for LMNB1: NuPAGE 4-12% Bis-Tris, for MYH6: NuPAGE 3-8% Tris-Acetate; 
Invitrogen). Each sample was loaded in triplicate for averaging purposes. Additionally, sample 
concentrations were adjusted to match LMNB1 signal whilst avoiding overloading and smearing, 
diluting the lysates with additional 1x NuPAGE LDS buffer if necessary. Gel electrophoresis was 
run for 10 min at 100 V and 1 hr at 160 V. After blotting on a polyvinylidene fluoride membrane 
with an iBlot Gel Transfer Device (Invitrogen), the membrane was blocked with 5% bovine serum 
albumin in TTBS buffer (Tris-buffered saline, BioRad; with 0.1% Tween-20). Membranes were 
incubated with primary antibodies against LMNB1 (#332000, raised in mouse, Invitrogen; used at 
1000-fold dilution) or MYH1/2/4/6 (sc-32732, raised in mouse, Santa Cruz; used at 1000-fold 
dilution) at 4 °C overnight. After washing, the membrane was incubated with 2000-fold diluted 
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anti-mouse HRP-conjugated IgG (GE Healthcare), at room temperature for 1 hour. The blot was 
developed with ChromoSensor (GenScript) for 3 min at room temperature. Blot images were 
obtained using a Hewlett-Packard Scanjet 4850. Densitometry was performed using ImageJ 
(version 1.45, National Institutes of Health).  Immunoblots were performed in triplicate, and the 
mean MYH6 densitometry results normalized to LMNB1 values were reported ± SEM.   
 
 
Micropipette aspiration of tissues  
Micropipettes were pulled from glass capillaries (World Precision Instruments, Sarasota, FL) with 
1 mm inner diameters using a Flaming-Brown Micropipette Puller (Sutter Instrument, Novato, 
CA).  Pulled tips were scored with the tapered base of another pulled pipette and broken to final 
inner diameters of 35-45 μm.  Pipettes were filled with PBS and attached to water-filled 
manometer-double reservoir set-up as described elsewhere [51].  Aspiration was performed at 
room temperature in PBS supplemented with 3% BSA, without Ca
2+
 to suppress beating.  Before 
each experiment, we incubated the pipette tip in PBS/BSA solution for ≥20 min to prevent tissue 
sticking inside the pipette.  During aspiration, ≥ 3 different pressures were applied from 0.5 – 1.4 
kPa for neural tissue and 0.5-20 kPa for cardiac tissue.  Aspiration experiments were imaged 
using a Nikon TE300 microscope with a 20x air objective and recorded using a Cascade 
Photometric CCD camera.  The effective Young’s modulus Et of the local tissue was obtained 
from the linearity between the difference between the applied pressure inside the pipette relative 
to outside (∆P) and strain L/Rp:     
  
   
  
 
  
    where L is the length of tissue aspirated 
measured from the mouth of the pipette, Rp is the pipette’s inner radius, and φo is a shape factor 
~2 [36]. 
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Cell mechanosensitivity assay   
We isolated cells from heart tissue by dicing to sub-millimeter size and then digesting with 
Trypsin/EDTA (Gibco, 25200-072).  To digest, we incubated tissue in approximately 1 mL Trypsin 
per E4 HT for 13 min rotating at 37˚C, for 2 min upright to let large tissue pieces settle before 
carefully removing supernatant and replacing with an equal volume of fresh Trypsin, and finally 
shaking for 15 more min.  We stop digestion by adding an equal volume of chick heart media.   
Cells were plated at concentrations of approximately 2x10^5 cells/cm directly on collagen I 
coated PA gels of varying stiffness [8].  E7 cells were preplated for 2 hours on tissue culture 
plates to allow fibroblasts to adhere before removing medium with nonadherent cells and plating 
those cells on collagen I coated PA gels.  Spontaneously beating cells were imaged using a 
Olympus I81 microscope with a 40x air objective configured for phase contrast after 24 hrs in 
culture, and recorded using a CCD camera at 23 frames/sec.  Movies were analyzed using a 
custom Matlab program to segment cells and track cell area and aspect ratio using the Matlab 
regionprops function.Strain was calculated for  3 sets of 3 hand-selected seed edge points that 
were subsequently automatically tracked with a custom Matlab tracking program during beating.  
The 2D plane strain tensor was calculated for each set of 3 points, throughout and the maximal 
trace of the strain tensor during contraction was calculated as a measure of strain for a given 
beat.  For each cell, at least 5-10 beats were analyzed.  Results were pooled from 4 separate 
experiments of E4 cardiomyocytes beating on 0.3, 0.9, 2.5, 10, and 40 kPa gels (n = 15, 38, 32, 
15, 8). 
 
Latrunculin Recovery Assay    
E7 cardiomyocytes were cultured on 11 kPa PA gels for 16 hrs. Cells were treated with 20 μM lat-
A. After 30 minutes, lat-A was removed. CMs were allowed to recover for 24 hours. In 
experimental samples (n = 32), 25 μM blebbistatin was added to the media during the full 
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recovery time. In control samples (n = 9), CMs recovered in the presence of plain media. 
Premyofibril formation was measured by immunofluorescence of sarcomeric α-actinin and non-
muscle myosin IIb, where s-α-actinin spacing less than 1.7 ± 0.02 μm or the presence of NMMIIb 
within striated patterns indicated premyofibril areas. 
 
Whole heart tube transfection  
Lipofectamine/plasmid complexes were prepared as prescribed by the manufacturers 
(Lipofectamine 2000, Invitrogen).  In particular, for each final 1 mL of transfection solution, 3-4 
micrograms of plasmid  (GFP or SIRPA-GFP [52]) and 10 μL Lipofectamine were each diluted to 
total volumes of 50 μL in Opti-MEM (Gibco, 31985-070) and stayed at room temperature for 5 
min before combining both solutions to make the final transfection solution which again sat at 
room temperature for an additional 25 min.  Heart tubes were preincubated in 0.9 mL pre-warmed 
chick heart media during lipofectamine/plasmid complex formation.  The lipofectamine/plasmid 
complex was added to the heart tubes in heart media and left to incubate at 37˚C 5% CO2 for 8-
12 hours.  Transfection media was replaced with prewarmed chick heart media and the heart 
tubes continued incubating until use in stiffening or softening experiments and subsequent 
imaging. 
 
 Tissue softening and stiffening treatments  
To soften collagenous ECM, tissue was incubated in solutions of Collagenase (Type XI, Sigma, 
C7657) in heart media  at 37˚C for the specified amounts of time, and rinsed 2x in heart media for 
2 min each.  Excised E4 HTs were incubated in 1.0 mg/ml, 0.3 mg/ml or 0.1 mg/ml Collagenase 
for 30 min.  Excised E6 HTs were incubated in 0.3 mg/ml collagenase for the short periods (10-30 
min) and long (50 min).  To stiffen, E4 tissue was incubated in 20 mg/mL transglutaminase 
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(Sigma, T5398) in chick heart media for 1 hr or 2 hrs at 37˚C  (n = 3, 5, respectively, over 2 
experiments).  Micropipette aspiration was used to measure stiffness of E4 heart tissue before 
treatment and after 1 hour and 2 hours transglutaminase treatment (n = 2, 2, respectively) in 
coincidence with untreated controls (n = 1, 1)(Fig. 1-S2A ) Similarly, micropipette aspiration was 
used to measure softening of E4 HTs before and after 1.0, 0.3, and 0.1 mg/ml collagenase 
treatment(n = 2, 3, 2) (Fig. 2-S2B).  For blebbistatin softening experiments, tissue was incubated 
in 20 μg/ml blebbistatin (EMD Millipore, 203390, stock solution 50 mg/ml in DMSO) in heart 
media for 30 min at 37 ˚C, and compared to a control of equal concentration of DMSO in heart 
media.   
 
Heart beat imaging and analysis  
GFP-transfected E4 chick hearts were imaged while beating by an Olympus I81, using 4x 
magnification, with phase-contrast and fluorescent illumination and movies were recorded using a 
CCD camera at rate of of 23 and 17 fps, respectively.  To calculate strain, ≥2 groups of 3 cells 
located within 20 microns of each other were hand chosen along the outer wall of anatomical 
region of interest (atrium, ventricle, or OFT) along the heart tube.   The same procedure and 
Matlab program were used to track cells and calculate 2D strain as was used to calculate cell-
edge strain for cells on gels.  Unless HTs were not beating, strain was measured and averaged 
for at least 5 beats.  The velocity of the contraction wave was calculated by dividing the distance 
along the heart tube between two groups of analyzed cell groups by the time difference their 
points of peak strains.  To visualize cellular calcium, hearts were loaded with Fluo-4 AM (Fluo-4 
AM F14217, Life Technologies)  for 30 min at room temperature prior to imaging, following the 
manufacturer’s protocol. 
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Myofibril striation imaging and analysis  
To visualize myofibril structure and organization in intact heart tubes and isolated 
cardiomyocytes, samples were stained for sarcomeric a-actinin-2, filamentous actin (TRITC-
phalloidin, Life Technologies) and DNA (Hoechst 33342).  Isolated cardiomyocytes and whole 
heart tubes were first incubated in relaxing buffer [53] for 5 min and 20 min, then fixed in 4% 
Formaldehyde for 5 min and 20 min, respectively.  They were then rinsed three times in blocking 
buffer (3% BSA in PBS), then left in blocking buffer for 1 hr at room temperature.  Samples were 
incubated in sarcomeric a-actinin-2 primary antibody (1:500 in blocking buffer) overnight at 4˚C 
rocking.  They were again rinsed 3x in blocking buffer before incubating in secondary antibody 
(1:1000 in blocking buffer) with TRITC-phalloidin (1:2000).  Finally, samples were incubated 10 
min in Hoechst 33342 (1:1000) in blocking buffer and mounted with mounting medium.  Cells on 
gels were mounted on coverslips  and sealed with clear nail polish imaged by wide-field 
fluorescence imaging with a 60x oil-objective.  All striated fibers were hand traced, and striation 
spacing was measured as the distance between peaks of the α-actinin image by a peakfinder 
program in Matlab.  Z-disc breadth was measured as the FWHM of the intensity profile 
perpendicular to the local myofibril direction, after subtracting the best fit linear trend line.  
Histograms of striation spacing for cells on gels fit to a bimodal: count = a*exp(-(s-μp)
2
/2σp
2 
+ 
b*exp(-(s-μm)
2
/2σm
2
 where s is the striation spacing bin, and a, b, μp, μm, σp, σm are best fit 
parameters.  Relative premyofibril and myofibril fractions of a/(a+b)  and b/(a+b) ± least squares 
fit error are respectively in Fig. 2-4E, and premyofibril and myofibril spacing respectively are μp ± 
σp and μm ± σm, in Fig. 2-4D.  To estimate the average z-disc breadth of premyofibrils vs. 
myofibrils, we took the striations with spacing ≤ 1.3 µm to be premyofibrils and ≥ 1.8 µm to be 
myofibrils and reported the mean ± SEM z-disc breadth associated with each respective 
population.   Whole untreated and treated HTs were imaged on a Zeiss LSM 710 confocal with a 
40x air-obective, with z-plane spacing of 0.48 µm.  Striation in intact heart was analyzed using 
ImageJ.  We converted the z-stack to a stack with z-plane spacing 0f 1.96 by grouped average 
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intensity z-projections of every 4 images.  For a given z-plane, we selected 5 random in-plane, 
unbranched sections of myofibrils at least 20 μm long using a random number generator to 
choose 5 random x-y coordinates from which we found the nearest candidate myofibrils.  We 
used planes 6, 16, and 26 µm into the ventricular tissue of untreated (n = 2 HT, m = 479 z-discs) 
and 0.3 mg/ml collagenase softened (n = 2 HT, m = 479 z-discs) E4 HT.  Z-disc spacing and 
breadth were calculated as described for myofibrils in the cells on gels.  The mean of all individual 
spacings and breadths ± SEM were taken for each condition.   
 
Box 2-1. Friedrich-Safran Model of Matrix Elasticity optimized Registration Force:  a Functional form 
Since striation is central to contractile function of any heart or skeletal muscle, a mathematical 
model of striation can help clarify striation mechanisms as well as processes dependent on 
striation, particularly the contractile strains measured here.  Friedrich et al. (2011) account for 
matrix elasticity effects and force generation in calculating how striated contractile fibers in cells 
on elastic substrates interact with each other and come into maximal registry on substrates of 
intermediate stiffness [45].  The myosin-II based contractile force that drives myofibril registry in 
the Friedrich-Safran (FS) model follows a non-monotonic form f ~ E / (Em + E)
2
 with a maximum 
at E = Em.  Striation organization dynamics in simulations were quantified in terms of a 
registration order parameter (i.e. ‘smectic’ order), and fit f
 n 
     Striation ~ [ E / (Em + E)
2
 ]
n
   (2-1) 
with n decreasing exponentially over time from n ≈ 1 to 0.6.  Importantly, high n gives a sharper 
peak at half-max than low n.  Moreover, because non-striated cardiomyocytes do not beat, 
striation is also key to rhythmic strains that we measured in tissue and isolated cells.  Matrix 
strain in cultures of sparse cells indeed fit well to Eq.2-1 with an optimal elasticity Em = 1.3 ± 0.3 
kPa and n = 1 (Fig. 2-3B).  This result is particularly remarkable because f is relatively restrictive, 
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with only one fitting parameter.  For the intact heart, Eq.2-1 also fits the measured strain with Em 
= 1.6 ± 0.2 kPa but with n = 4 ± 1 (Fig. 2-2C).  The higher exponent quantifies the much sharper 
peak for tissue, indicating a greater sensitivity to matrix elasticity in tissue compared to cells in 
sparse 2D cultures.   
 
Box 2-2. Mechanical Signaling Model for Contractile Waves 
Based only on Excitation-Contraction Coupling, the contractile wavefront speed should not 
depend on matrix elasticity.  The excitable medium model here is linear in Et:  cells are coupled 
mechanically through extracellular matrix and cell contractions are triggered by mechanosensitive 
means, namely Excitation-Contraction-Matrix Coupling (see Supplement).  The heart tube is 
considered per a two-fluid model [27] with isotropic linear elasticity (matrix plus cells) of elasticity 
E and Poisson ratio ν as well as tissue viscosity η.  Damping forces couple viscous and elastic 
components through a coupling constant Γ. 
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Here δ(x) is the Dirac delta function, Θ(t) the Heaviside step function, and Δt the duration of the 
contraction. The wavefront speed depends on two material parameters: an effective “diffusion 
constant” D = E / Γ, and a relaxation time τ = 2 η (1+ν) / E.   A predicted threshold value of E0 = 
0.1Euntreat, below which the system is too soft to support a contractile wavefront, is consistent with 
observations that – with softening treatments – the contraction wave failed to propagate 
sometimes into the ventricular region, which is softer than the atrium (Fig 2-S1B). The probability 
of propagating indeed decreased monotonically with softening (Fig. 2-S2I).  Failure to propagate 
when E > Eo could be due to inhomogeneities in stiffness.  Intriguingly, the stiffness of embryonic 
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heart when it first begins to beat at E2 is also roughly 0.1Eadult (Fig. 2-1C), which is several-fold 
stiffer than the embryonic disc.  
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2-4: Supplemental Analysis 
Mechanical Signaling Model for Contractile Waves 
It is well recognized in biological contexts such as Dictyostelium [54] that chemical signaling can 
proceed via propagating wavefronts if a local increase in concentration of some chemical species 
can trigger further release of that species at that same location, thus amplifying the signal. 
Analogously, we propose that mechanical signaling can proceed via the propagation of nonlinear 
contractile wavefronts through mechanically excitable heart tissue. When a cell contracts, it 
exerts a stress on the surrounding tissue.  We approximate this stress as a dipole that conserves 
the volume of the contracting cell by expanding it perpendicular to the contraction. We denote the 
strength of the dipoles by Q.  Note that tissue itself cannot sustain mechanical (sound) waves 
because they are damped out exponentially. However, a wave can be maintained if it is 
continually amplified. In our model, we assume that each cell contracts once the local stress 
exceeds a certain threshold value α. This could occur, for example, if calcium release is triggered 
by stress [55, 56].   By contracting, a cell adds stress to the system, thus amplifying the signal.  
This mechanism can lead to a wavefront that moves at constant velocity down the heart tube. 
More precisely, we treat the heart tube as a two-fluid model [57]. We model the tissue as having 
an elastic component (in matrix plus cells) that obeys isotropic linear elasticity and is 
characterized by the Young’s modulus E and Poisson ratio ν. The tissue also has a viscous 
component that obeys the Stokes equation, is characterized by a viscosity η and is 
incompressible. Damping forces couple the viscous and elastic components of the material 
through a coupling constant Γ. 
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Here δ(x) is the Dirac delta function, Θ(t) the Heaviside step function, and Δt the duration of the 
contraction. The wavefront speed depends on two material parameters: an effective “diffusion 
constant” D = E / Γ, and a relaxation time τ = η / μ  = 2 η (1+ν) / E, where μ is the material’s shear 
modulus. Additionally, the speed depends on two dimensionless parameters: the Poisson ratio ν 
and the rescaled threshold α = a
3
 α / Q, where a is the spacing between the cells. By purely 
dimensional considerations, there are two ways to construct a quantity with the dimensions of a 
speed: D/a and a/τ. Because both scale linearly with E, we can immediately conclude that the 
wavefront speed v should scale with E as well. We have confirmed this by solving the model 
numerically. A full dimensional analysis shows that v ~ E a
1-2n
 Γ
-n
 η
-(1-n)
, where n is a number 
between 0 and 1 that depends on the dimensionless parameters v and α.  For fixed Poisson ratio 
ν = 0.4, which is reasonable for soft tissues [8], we found numerically that n depends strongly on 
the dimensionless threshold stress α, increasing from 0.2 for α = 0.5 to 0.4 for α = 0.75.  At 
sufficiently high values of α, or equivalently, sufficiently low values of E, the tissue becomes too 
soft to trigger cells to contract; below that threshold (which we denote by E0) the wavefront can 
fail to propagate (v=0). 
Pipette aspiration measurements show the ventricle has an effective viscosity η ≈ 25 Pa·s, and 
since this changes by only 20% for the stiffened and softened tissues, we treat it as constant. The 
coupling constant Γ is estimated by assuming the largest contribution arises from the relative 
motion of the cytoskeleton with respect to the cytoplasm. Therefore Γ ~ η/x
2
, where x is the 
displacement during contraction, which we take to be 5 μm, or half the radius of the cell, so that Γ 
~ 1 Pa·s / (μm)
2
.  We find α by fitting the numerical results to the slope of the (E, v) data for the 
ventricle, which is 13 mm/(kPa·s), and the one-parameter fit yields α ≈ 0.5.  The threshold for 
initiating contractions is thus about half the force per unit volume exerted by the cells themselves 
while contracting.  
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Figure 2-1: Mechanical development of heart and brain tissue parallels expression of 
abundant cell and matrix proteins. (A) E3 chick embryo with heart tube (red line) and midbrain 
(blue line) outlined in situ and after isolation.  The heart continues to beat ex vivo, with contraction 
and flow propagating along the dashed turquoise line.  Scale bars represent 100 µm. (B) 
Micropipette aspiration of the inner curvature of an E3 heart tube, with close-up of aspirated 
tissue in phase contrast image.  Scale bar represents 10 µm. (C) Representative 
aspiration/relaxation curves for E4 heart and brain demonstrate the elastic and viscoelastic 
behavior of the tissues, respectively, as discussed in the text.  L, Rp and ∆P = Pin-Pout are 
illustrated in (B).  (D) Et for heart and brain tissue throughout embryonic development, starting 
with day-1 embryonic disk (n = 2 embryos), then E2, E4, E6, and E14 heart and brain (n ≥3 
measurements each), respectively.  By the time beating starts, the heart tube is already 3-fold 
stiffer than early embryonic tissue and then stiffens at a rate of ~ 0.3 kPa/day (solid red line).  
Due to the thick epicardium of E6 hearts and older relative to the inner diameter of our 
micropipettes, measurements likely underestimate stiffness of the myocardium at those stages 
due to significant contribution of epicardium.  Brain tissue does not stiffen during development 
and remains viscoelastic with a mean Et = 0.3 kPa. (E) Quantitative mass spectrometry (MS) of 
cellular proteins extracted from intact embryonic disc (Hamburger-Hamilton stage 3-4), E2, E3, 
E4, and E10 heart and brain tissue reveals a small set of detected proteins with expression 
patterns similar to heart or brain mechanics: namely, a general increase in heart and relatively 
little to no increase in brain.  Expression is relative to average in brain E2-E3 (n ≥3 MS 
measurements).   (F) Immunoblot confirms that MS measurements of Cardiac Myosin expression 
increase in heart during development.  Samples represent pooled tissue from 3-4 embryos at 
each reported stage and were normalized to Lamin B1 (n ≥3).  (G) MS indicates that collagen-I 
expression increases during heart development, but not greatly during brain development. Inset 
images:  1% SDS-decellularized E4 and E14 hearts. The insoluble matrices retain the shape of 
the embryonic hearts, but while E14 matrix (80% of MS ion current is collagen-1) appears solid, 
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the E4 matrix appears more reticulated and porous, consistent with having less mass.  (G) Of the 
209 proteins identified by Mass-Spec (Table S1), only 17 had expression levels across tissues 
and development that paralleled mechanics.  Error bars in all figures represent SEM.   
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Figure 2-2: Effect of extracellular matrix softening and stiffening on heart tube beating  (A) 
Extracted E4 heart viewed with phase contrast (i) and fluorescent imaging (ii) following sparse 
transfection with GFP.  Scale bar = 100 μm.  Three GFP-expressing cells used to calculate strain 
during beating are tracked from their relaxed (iii) to contracted (iv, scale bar = 20 μm) positions.  
Strain is schematized in (v) and described in [58]. (B) SIRPA-GFP-expressing cell in transfected 
E4 heart tissue before and after softening. Overlays of SIRPA-GFP expressing cells over time 
help visualize any cell conformational changes during contraction and softening treatments.  
Overlay of the same cell pre-treatment while relaxed (green) and contracted (red) (bottom-left) 
shows less overlap (yellow) than the relaxed cell before and after softening of the tissue.  This 
suggests that cells maintain morphology and adhesions during softening treatment. (C)  Tissue 
strain during beating of GFP-transfected softened and stiffened E4 HT normalized to that of 
untreated and the resulting relative strain averaged for atria, ventricles, and outflow tract.  
Softened and stiffened tissues suppress contractions.  Typical peak strains throughout the 
untreated heart tube were 10 ± 4%. The dashed curve is a fit to Eq. 1 with n = 4 ± 1 and Em=1.6 ± 
0.2 kPa.  (D) E6 hearts treated with collagenase stop beating or beat partially with greater 
frequency over time of treatment.  Beating is significantly hindered after 50 min softening 
treatment, relative to untreated or briefly (10-30 min) treated hearts.  E6 hearts show clear 
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softening by 50 min softening treatment, unlike briefly treated hearts, which correlates with 
decrease in beating function.  Insets are representative aspiration-relaxation curves for mildly and 
significantly softened hearts given the same 50 min softening treatment, in which red represents 
the untreated tissue and blue represents the treated tissue.  (E) Velocity of the contraction wave 
through the ventricle vs normalized Et. Wave-speeds in untreated ventricle, atria, and outflow 
tract of 22±4 mm/s, 4±2 mm/s and 2.8±0.7 mm/s, respectively, are consistent with past work [59].  
For the most extreme stiffening treatment, contraction does not propagate past the presumptive 
pacemaker. The velocity in the ventricle increases linearly with tissue stiffness, consistent with 
theory. The dashed line is the theoretical prediction with a single adjustable parameter, namely 
the ratio of the stress threshold to the magnitude of the force dipole corresponding to a 
contracting cell. Eo indicates the theoretically predicted stiffness below which a contraction wave 
should not propagate. Error bars for all figures represent SEM (n ≥3 hearts). 
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Figure 2-3: Isolated cardiomyocytes are sensitive to matrix stiffness, with striation 
dependent on actomyosin work.  (A) Cardiomyocytes were imaged beating in culture after 18-
24 hr in culture.  Morphologies in the relaxed and contractile states and contractile strains were 
measured for beating cells.  (B) Edge-strain of cardiomyocytes cultured on PA gels of various 
stiffnesses, measured as the trace of the 2D strain-matrix of cell edge points during beating, as 
described in methods.  In beating, cell and matrix strain is strongly modulated by substrate 
elasticity with an optimal Egel similar to that of E4 heart and much lower than that measured for 
more mature cells ( [8, 10]).  Softer and stiffer substrates impede beating of cultured cells.  The 
Lorentzian fit gives Em = 1.3 ± 0.3 kPa, consistent with the tissue elasticity of E4 hearts (Et = 1.3 
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± 0.4 kPa in Fig. 2-1).  (C-D) Representative image of E7 cardiomyocytes recovering from 
latrunculin-A (Lat-A) treatment in the presence (C) or absence (D) of blebbistatin, which does not 
affect cell viability [35]. (E) Myofibril assembly was measured as the percentage of cell area 
covered by mature myofibrils (sarcomere spacing > 1.5 μm). Inhibition of beating and actomyosin 
contractility by blebbistatin reduces the amount of new myofibrils formed following Lat-A washout 
and causes mature myofibrils to disassemble per (C).  Inset shows that for these late embryo 
cardiomyocytes, the optimal elasticity for rapid recovery of striated pre-myofibrils is close to that 
of adult heart (Et ~ 10-15 kPa).   Error bars are SEM (n ≥3 cells).  (*) p < 0.05. 
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Figure 2-4: Sarcomere breadth changes in softened heart and in isolated cardiomyocytes 
on compliant substrates. (A) Untreated and softened whole E4 hearts were immunostained for 
sarcomeric α-actinin-2, F-actin, and DNA and imaged by confocal microscopy.  Sarcomere 
spacing and Z-disc breadth (inset) were measured to assess any structural changes.  (B) Z-disc 
breadth is significantly decreased in the 47%-softened heart relative to untreated controls. The 
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decreased registry of myofibrils suggests a decreased coupling between adjacent myofibrils 
during contraction. Sarcomere spacing is consistent with mature myofibril sarcomere spacing and 
is not significantly different in the softened and untreated hearts.  (C) E4 cardiomyocytes cultured 
on gels were stained in the same way as the whole hearts of figure A. Figure shows typical E4 
cardiomyocytes on gels with stiffnesses of 0.3, 3.0 and 10 kPa.  (D) Striation spacing was 
bimodal in distribution, indicating mature myofibrils (sarcomere spacing > 1.8 μm) as well as pre-
myofibrils (sarcomere spacing < 1.4 μm).  (E) Fraction of each type of striation per cell with 
myofibrils maximal on gels where pre-myofibrils are minimal.  We fit the fraction of myofibrils with 
fm = f (Eq. 1), (blue dashed line) and pre-myofibrils with        , finding Em = 9 ± 2 kPa.   (F) 
Z-disc breadth for myofibrils and pre-myofibrils were maximized on substrates of intermediate 
stiffness. The fits to Eq. 1 yield Em = 1.7 ± 0.3 kPa for pre-myofibrils and Em = 4.2 ± 0.6 kPa for 
myofibrils.   Error bars are SEM (n ≥3 hearts or cells) 
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Figure 2-S1: Anatomically distinct mechanics of embryonic tissue can be softened 
differentially by disrupting cytoskeleton or collagenous matrix.  (A) Example Stress/Strain 
curve of an E4 Heart Tube ventricle. From Eq. 1, Et = 1.7 ± 0.1 kPa.  (B) Anatomical differences 
in Et are measured along the E2-E4 heart tubes that reflect functional developmental changes 
(AVJ = atrioventricular junction, OFT = outflow tract). (C) As a check for the protein quantification, 
we compared the relative amounts of α and β Spectrins and Col Ia1 and Ia2.  Since these 
spectrins and collagens should normally be found at ratios of 1:1 and 2:1, respectively, their 
normalized abundances should be equal across all samples, which is what we find. (D) Of the two 
ECM proteins identified, Collagen-I and Fibronectin, only Collagen follows the trends of the tissue 
mechanics.  Several mitochondrial proteins were also identified to follow the trends of the tissue 
mechanics, but generally not as strongly and at a lower abundance than the excitation-
contraction coupling proteins discussed in the text.  (E) Treatment of E2, E4 and E14 heart and 
E14 brain (5 measurements each of n = 4, 4, 2, 2, respectively) with blebbistatin softens the 
tissues significantly, allowing us to estimate of the contribution of actomyosin contractile forces to 
tissue mechanics (~25% for heart and ~50% for brain).  (F) Treatment of E4 and E14 heart and 
E14 brain (5 measurements each of n = 4, 2, 3, respectively) with collagenase shows that a 
significant softening of the heart tissue (~ 40%), but no softening of the brain tissue.  Due to the 
thick epicardial layer of E4 heart, the softening of myocardium due to collagenase is likely 
underestimated.  (G) Immunoblot of E6 hearts treated for 50 min with collagenase that had 
stopped beating (n = 3) and continued beating (n = 2) shows no significant difference in myosin 
expression.  Error bars are ± SEM (n ≥ 3 unless indicated). 
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Figure 2-S2: Effects of dose-dependent stiffening and softening of E4 embryonic cardiac 
tissue by transglutaminase and collagenase on intact tissue structure and function  (A) 
Change in tissue stiffness as a function of treatment time with 20 mg/mL transgluatminase (purple 
triangles, filled triangles represent the intermediate and extreme stiffening treatments used in the 
strain and velocity measurements) and different concentrations of collagenase (red circles 0.1 
mg/mL, blue squares 0.3 mg/mL, green diamonds 1.0 mg/mL). Treatment with transglutaminase 
leads to stiffening whereas collagenase treatment softens the tissue.  (B) Softening of tissue as a 
function of collagenase concentration for 30 min treatments. We assume the collagenase acts 
with Michaelis-Menten kinetics, so fit the data with 
        
          
 
 
               
 , finding   = 0.26±0.08 
mg/ml and   = 0.27±0.1 mg/ml. Inset shows aspiration and relaxation of a 0.1 ml/mg collagenase 
softened E4 HT tissue including a GFP-expressing cell, demonstrating that individual cells return 
to their original shape and position upon relaxation from applied strain.  Also in inset are sample 
aspiration curves for tissues before (blue) and after (red) softening and stiffening.  (C) After 30 
min, fluorescently labeled collagenase perfusion of an E4 HT shows that the tissue is fully 
perfused with the enzyme.  Black arrows indicate possible trabeculae. (D) Overlays of SIRPA-
GFP expression by transfected cells in beating E4 HTs before (green) and after (red) collagenase 
treatment show that treatment does not significantly alter cell membrane contour and thus likely 
does not significantly interfere with cell adhesions.  (E) Un-normalized strain and (F) velocity 
measured from analysis of fluorescent imaging of GFP-transfected heart tubes that have been 
softened or stiffened.  (G) Ca2+ wave velocity in untreated and softened heart tubes.  The Ca2+ 
imaging allowed for more precise localization of the Ca2+ wave than the strain wave, so the 
atrioventricular junction (AVJ) could be differentiated from the atrium and ventricle.  The strain 
wave velocity measurements across the atrium and ventricle were made from the initiation of 
contraction to the AVJ and then from the AVJ to points in the presumptive right ventricle, 
respectively.  Therefore the strain wave atrium and ventricle include time from the AVJ and so are 
measured to be slower than the Ca2+ wave. The Ca2+ wave is coincident with the initiation of 
contraction in the heart, and therefore shows the same trends in velocity as the strain wave with 
softening.  (H) Beat frequency in each chamber decreases with softening and does not 
significantly change with stiffening, except in the stiffest condition in which the contraction wave 
does not propagate past the atrium. (I) Similarly, probability of contraction propagating decreases 
with softening but does not significantly change with slight stiffening and drops to zero in the 
extreme stiffening condition 
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Figure 2-S3:Changes in E4 cardiomyocyte aspect ratio and area during contraction are 
optimized by intermediate substrate stiffness (A) Cell aspect ratio and area, schematized at 
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left, are significantly modulated by substrate elasticity.  The peak in cell aspect ratio fits a 
Lorentzian (see Box 1) peaked at Em = 10 ± 4 kPa, whereas cell area fits a generalized Hill 
equation with a mid-point of 2 ± 1 kPa.  (B) Representative images of ESC-CM stained for a-
actinin to visualize z-discs after being cultured on soft, intermediate, and stiff substrates for 4 
days.  (D,E,F) Representative image of ESC-CM after 6 days cultured on elastic substrates. 
Defects reminiscent of disclinations and dislocations in liquid crystals (upper inset) and cracks 
(lower inset) arise in the myofibril organization of ESC-CM cultured on stiff substrates. (C) Mature 
myofibril content quantified by % of total cell area is maximized on intermediate stiffness 
substrates after 4 days in culture. Myofibril content decreases further in cells grown on soft 
substrates and is maintained in intermediate to stiff substrates (data not shown). (D)  Mature 
myofibril spacing of cells cultured on stiff substrates shows increased variance relative to that of 
cells grown on intermediate substrates.  (E) Edge velocities of spontaneously beating ESC-CM 
cultured for 4 and 6 days on soft, intermediate, and stiff substrates.  After just 4 days, edge 
velocity decreases with increasing stiffness, reflecting the increased load that the beating cell 
feels on different substrates.  After 6 days, ESC-CM stop beating on the softest substrates, and 
two populations can be seen on the intermediate and stiff substrates, indicating possible further 
differentiation into fast-contracting “atrial” type cells and slow-contracting “ventricular” type cells 
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Name (Gene) 
Brain 
E10/ 
Brain 
E4/ 
Emb 
Disc/ 
Heart 
E2/ 
Heart 
E3/ 
Heart 
E4/ 
Heart 
E10/ 
Brain 
E2 
Brain 
E2 
Brain 
E3 
Brain 
E2 Brain3 
Brain 
E2 Brain E2 
Vitellogen II (VTGII) -1.22 -0.13 5.36 2.92 2.84 0.16 -0.93 
Vitellogen I (VTGI) -0.69 0.07 5.57 2.96 2.8 0.27 -0.54 
Apolipoprotein B (APOB) -0.7 0.19 4.5 3.14 2.66 0.56 -0.23 
Ovalbumin (SERPINB14) -1.22 0.68   3.13   1.32 -0.78 
Titin isoform N2-A (TTN) 0.49 1.22 2.95 2.56 3.75 2.1 2.38 
Ovotransferrin (TFEW) 0.42 0.96   3.32   1.43 0.95 
Fibronectin (FN) 1.67 2.32 1.89 2.9 3.04 2.7 2.4 
T-complex protein 1 
subunit epsilon (CCT5) 1.93 2.26   2.54   2.47 2.2 
Paranemin 1.78 2.37 1.07 2.74 2.66 2.63 2.58 
Spectrin alpha chain, 
brain (SPTA), 
Nonerythroid alpha-
spectrin fragment overlap 2.28 2.25 2.25 2.47 2.58 2.53 2.87 
Spectrin alpha chain, 
brain (SPTA) 2.36 2.09 2.27 2.3 2.56 2.46 2.77 
Spectrin beta chain, brain 
1 (SPTBN1) 2.32 2.12 2.22 2.19 2.53 2.47 2.76 
Lamin B2 (LMNB2) 1.96 2.29   2.12   2.19 2.78 
Creatine kinase B-type 
(CKB) 2.06 2.54   1.94   2.26 2.57 
Talin (TLN) 2.18 2.34 1.87 2.28 2.63 2.59 2.84 
Vimentin (VIM) 2.07 2.62   2.36   2.51 2.82 
Eukaryotic translation 
elongation factor 1 2.08 2.4   2.28   2.31 2.49 
SMARCA4 (BRG1)     2.09   1.84     
Heterogeneous nuclear 
ribonucleoprotein R 
(HNRNPR) 1.93 2.63   2.31   2.46 2.43 
Malate dehydrogenase, 
cytoplasmic (MDH1) 2.04 2.48   2   2.7 3.08 
Aspartate 
aminotransferase, 
mitochondrial (GOT2) 1.81 2.3   2.17   2.68 3.05 
Smooth muscle gamma 
actin; alpha skeletal 
muscle; aortic smooth 
muscle; alpha cardiac 
muscle 1 [overlap] 0.75 1.42   2.81   2.52 3.25 
Ubiquitin carboxyl-
terminal hydrolase 10 
(USP10)     1.72   2.08     
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Succinyl-CoA:3-ketoacid-
coenzyme A transferase 
1, mitochondrial (OXCT1) 2.57 1.97   2.74   2.51 3.92 
Nuclear pore complex 
protein Nup205 
(NUP205)     2.56   1.98     
Albumin (ALB) 2.59 2.25   3.84   2.53 2.93 
Collagen alpha-2(I) chain 
(COL1A2) 2.49 2.59   2.24   1.94 3.68 
CCR4-NOT transcription 
complex subunit 1 
(CNOT1)     1.82   1.75     
Sterol O-acyltransferase 
1 (ACAT1) 2.4 2.52   2.33   2.92 3.55 
Isocitrate dehydrogenase 
[NADP] 2.26 2.3   2.46   2.78 3.72 
Collagen alpha-1(I) chain 
(COL1A1) 2.22 2.56 1.44 2.46 2.74 1.98 3.58 
SERCA2 (ATP2A2) 1.94 2.12 2.62 2.58 3.33 2.89 2.97 
Alpha actinin-1/2/4 
(ACTN-1/2/4) 1.5 1.83 2.53 2.47 3.66 2.23 2.61 
Sodium/potassium-
transporting ATPase 
subunit alpha-1 
(ATP1A1) 1.66 2 3.2 2.16 3.06 2.39 2.69 
Radixin (RDX) 1.68 2.23   2.27   2.47 2.54 
Glyceraldehyde-3-
phosphate 
dehydrogenase 
(GAPDH) 1.86 2.05   2.31   2.5 2.57 
ATP synthase subunit 
alpha (ATP5A1) 1.87 1.98   2.2   2.55 2.85 
Similar to Cytoskeleton-
associated protein 5 
(CKAP5) 1.84 1.96 1.89 2.37 2.06 2.61 2.76 
Malate dehydrogenase 
(MDH2) 1.48 1.91   2.49   2.61 2.89 
ATP synthase subunit 
beta, mitochondrial 
(ATP5B) 1.48 2.07   2.38   2.6 3.02 
CFR-associated protein 
p70 1.29 1.94   1.86   2.67 2.81 
Prohibitin-2 (PHB2) 1.44 1.54   2.1   2.36 2.04 
Voltage-dependent 
anion-selective channel 
protein 2 (VDAC2) 1.72 1.63   2.12   2.52 2.28 
T-complex protein 1 
subunit alpha (CCT1) 1.73 2.3   1.84   1.98 2.18 
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similar to chaperonin-
containing TCP-1 
complex gamma (CCT3) 1.55 2.29   2.05   2.11 2.17 
Transcriptional 
coactivator p100     2.3   2.41     
Peptidyl-prolyl cis-trans 
isomerase (FKBP4) 1.45 2.33   2.09   1.74 2.24 
Spliceosome RNA 
helicase (DDX39B) 1.52 2.14   1.56   1.97 2.16 
Calreticulin (CALR) 1.48 1.98   2.33   2.26 2.42 
26S proteasome non-
ATPase regulatory 
subunit 12 (PSMD12) 1.49 2.22   1.94   2.38 2.34 
SMARCA5 (SMARCA5)     2.43   1.87     
Nucleoporin 133 kPa 
(NUP133)     2.52   1.94     
Fructose-bisphosphate 
aldolase C (ALDOC) 1.74 1.97   2.09   2.28 2.31 
T-complex protein 1 
subunit beta (CCT2) 1.47 1.99   2.01   2.14 2.07 
Ribosomal protein L4 
(RPL4) 1.27 2.15   2.1   2.16 2.26 
60 kDa heat shock 
protein, mitochondrial 
(HSPD1) 1.12 1.7   1.98   2.19 2.11 
Protein disulfide-
isomerase (P4HB) 0.99 1.85   1.99   2.04 2.39 
Probable global 
transcription activator 
SNF2L2 (SMARCA2)     2.11   1.77     
Stress-70 protein, 
mitochondrial (HSPA9) 0.83 1.87   1.95   2.1 2.23 
Vinculin (VCL) 0.96 1.78 2.26 2.11 2.92 2.05 2.16 
Microtubule-actin cross-
linking factor 1 (MACF1) 2.5 1.25 1.59 2.7 1.82 1.61 1.19 
Nuclease-sensitive 
element-binding protein 1 
(YBX1) 2.1 1.15   2.1   1.66 1.61 
Neurocan core protein 
(NCAN) 2.43 1.43   2.25   1.51 1.22 
Similar to Transcription 
elongation regulator 1 
protein (TCERG1)     1.73   1.74     
High molecular mass 
nuclear antigen     1.76   1.93     
Lamin-B1 (LMNB1) 2.17 1.42   2.03   1.6 1.18 
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SMC2 cohesin complex 
subunit (SMC2)     1.73   1.54     
Microtubule-associated 
protein (MAP2) 2.5 1.26   2.16   1.04 1.37 
Heat shock protein HSP 
90-alpha (HSP90AA1) 1.82 1.11   2.34   1.61 1.08 
Microtubule-associated 
protein (MAPT) 3.39 1.37   1.97   1.91 1.61 
Claustrin, MAP1B 
[overlap] 3.02 1.73 0.95 2.37 1.28 2.07 1.44 
Microtubule-associated 
protein 1B (MAP1B) 2.83 1.86 0.99 2.58 1.24 1.84 1.46 
Collapsin response 
mediator protein-1A 
(CRMP1A) 2.76 2.42   2.96   2.04 2.22 
Cytoplasmic dynein 
(DYN1) 3.05 2.25 1.61 2.8 1.9 2.33 2.18 
Tubulin beta-4 chain 3.09 2.42   2.77   2.38 2 
Neural cell adhesion 
molecule 1 (NCAM1) 2.89 2.06 1.31 2.59 2.49 2.27 2.2 
Nuclear autoantigenic 
sperm protein (NASP) 0.63 1.7 2.52 1.7 1.92 1.26 0.93 
Splicing factor 3b, 
subunit 3, 130kDa 
(SF3B3) 0.75 1.7 2.34 1.76 2.16 1.26 0.9 
Filamin 1.08 1.67 1.64 1.69 2.09 1.29 1.45 
Eukaryotic translation 
initiation factor 4 gamma 
1 (EIF4G1) 1.2 1.74 1.59 1.8 2.07 1.66 1.37 
60S acidic ribosomal 
protein P0 (RPLP0) 1.29 1.54   1.93   1.65 1.56 
Elongation factor 1-alpha 
1 (EEF1A) 0.77 1.86   1.71   2.09 1.69 
ATP-dependent RNA 
helicase (DDX3X) 0.8 1.65   1.59   2.05 1.6 
Nuclear calmodulin-
binding protein (URP)     2.21   2.08     
Pyruvate kinase muscle 
isozyme (PKM2) 0.78 1.65   1.78   1.94 1.71 
Alpha-enolase (ENO1) 0.99 1.68   1.57   1.85 1.67 
Spicing factor 3A subunit 
1 (SF3A1)     1.85   1.97     
Insulin-like growth factor 
2 mRNA-binding protein 
3 (IGF2BP3) 1.05 2.18   1.37   1.63 1.77 
Phosphoglycerate kinase 
(PGK) 1.3 1.95   1.51   2 1.94 
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Leucine-rich PPR motif-
containing protein 
(LRPPRC) 1.29 1.77 2.83 1.56 2.33 1.71 1.99 
Heterogeneous nuclear 
ribonucleoprotein H1-like 
protein 1.14 1.81   1.76   1.81 1.88 
SERPINE1 mRNA 
binding protein 1 
(SERBP1) 1.05 1.78   1.71   2.05 2.01 
40S ribosomal protein SA 
(RPSA) 1.23 1.77   1.92   2.08 1.92 
Nucleophosmin (NPM1) 0.3 1.59   1.89   1.8 1.49 
DNA topoisomerase 2-
beta (TOP2B) 2.34 2.11 1.21 2.3 1.81 1.79 1.84 
Dynactin subunit 1 
(DCTN1) 2.35 1.78 1.1 1.74 1.77 1.71 1.83 
Collapsin response 
mediator protein-4B 
(CRMP4B) 2.95 1.55   2.5   1.95 1.99 
UDP-
glucose:glycoprotein 
glucosyltransferase 1 
(UGGT1)     2.74   2.32     
Tenascin (TNC) 2.61 1.59   2.63   1.74 1.35 
Catenin alpha-2 
(CTNNA2) 2.25 2   2.78   1.93 1.99 
SMC1 protein cohesin 
subunit (SMC1)     2.08   1.7     
Doublecortin (DCX) 2.68 1.73   2.2   1.64 1.52 
Eukaryotic translation 
initiation factor 5B 
(EIF5B)     1.97   1.91     
Sister chromatid 
cohesion protein PDS5 
homolog B (PDS5B)     1.75   1.67     
Myristoylated alanine-rich 
C-kinase substrate 
(MARCKS) 3.03 1.98   2.04   1.84 1.75 
Heterogeneous nuclear 
ribonucleoprotein A3 
(HNRPA3) 2.65 1.96   1.96   2.06 1.91 
cardiac and cytoplasmic 
actin [overlap] 2.61 1.68   2.14   2.26 2.41 
Hexokinase 1 (HK) 2.24 1.71   2.24   2.47 2.62 
Exportin-5 (XPO5)     1.9   1.81     
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Mitochondrial ubiquinol-
cytochrome-c reductase 
complex core protein 2 
(QCR2) 2.25 1.77   1.95   2.57 3.02 
Nucleolin (NCL)     2.61   1.93     
Guanine nucleotide-
binding protein 
G(I)/G(S)/G(T) subunit 
beta-3 (GNB3) 2.31 1.8   2.19   2.37 2.07 
Reticulon-4 isoform A2 
(NOGO) 2.37 2.21 1.53 1.86 2.27 2.27 2.15 
Heterogeneous nuclear 
ribonucleoproteins A2/B1 
(HNRNPA2B1) 2.39 2.19   1.98   2.2 2.22 
Rab GDP dissociation 
inhibitor (GDI) 2.38 2.18   2.15   2.06 2.06 
Desmoplakin (DSP)     3.25   3.7     
AP-2 complex subunit 
alpha-2 (AP2A2) 2.36 2.35   2.21   2.12 1.95 
Septin-7 (SEPT7) 2.11 2.12   2.15   1.92 2.36 
Neuron-glia cell adhesion 
molecule (Ng-CAM) 2.1 1.81   2.15   2.1 2.14 
SMC3 cohesin complex 
subunit (SMC3)     2.07   1.76     
Tubulin beta-2 chain 2.02 2.1   2.17   2.06 2.26 
Protein disulfide-
isomerase A3 (PDIA3) 2.16 2.19   2.03   2.08 2.48 
Serine/arginine-rich 
splicing factor 1 (SRSF1) 2.06 2.23   1.69   1.9 2.12 
AP-2 complex subunit 
beta (AP2B1) 2.18 2.14   1.81   2.15 2.15 
2-oxoglutarate 
dehydrogenase, 
mitochondrial (OGHD)     2.7   3.02     
T-complex protein 1 
subunit theta (CCT8) 1.98 2.21   1.84   2.11 2.16 
Tubulin beta (TUBB) 2.1 1.95   1.97   1.99 1.95 
Tubulin alpha-1 chain 
(TUB1) 2 1.89   1.98   1.93 1.86 
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Thyroid hormone 
receptor associated 
protein 3 (THRAP3)     1.17   1.69     
26S proteasome non-
ATPase regulatory 
subunit 2 (PSMD2) 1.97 2.21   1.95   1.93 1.76 
78 kDa glucose-
regulated protein 
(HSPA5) 1.95 2.03   1.97   2 2.23 
Kinectin (KTN1) 2.27 2.17 2.82 1.92 1.97 2.02 2.11 
Dihydropyrimidinase-
related protein 2 
(DPYSL2) 2.46 2.1   1.93   1.93 2.12 
T-complex protein 1 
subunit zeta (CCT6) 2.15 1.74   1.73   2.18 2.05 
Heterogeneous nuclear 
ribonucleoprotein K 
(HNRNPK) 2.17 2.06   1.7   2.13 1.95 
Kinesin-1 heavy chain 
(KIF5B) 2.43 2.16 2.01 1.43 2.15 2.14 1.91 
Similar to scaffold 
attachment factor B 
(SAFB) 1.96 2.21 2.08 1.57 1.77 1.71 1.64 
Coatomer subunit beta 
(COPB1) 2 2.03   1.46   1.88 1.79 
GTP-binding nuclear 
protein Ran (RAN)     2.46   1.66     
Golgi apparatus protein 1 
(GLG1) 2.12 2.28 2.38 1.55 1.84 1.91 1.77 
Similar to Splicing factor 
Prp8 (PRPF8) 1.91 1.95 2.25 1.78 1.93 1.59 1.6 
U5 small nuclear 
ribonucleoprotein 200 
kDa helicase 
(SNRNP200) 1.91 1.93 2.23 2.11 1.92 1.56 1.81 
T-complex protein 1 
subunit eta (CCT7) 2.08 1.89   2.09   1.62 1.97 
Nonmuscle myosin 
heavy chain 1.72 1.92 1.92 1.71 1.94 1.77 1.92 
Nonmuscle myosin 
heavy chain, Myosin-9 
[overlap] 1.73 1.84 2.14 1.96 1.95 1.77 1.87 
T-complex protein 1 
subunit delta (CCT4) 1.59 1.72   1.85   1.91 1.8 
Similar to THO complex 
2 (THOC2)     2.08   1.81     
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60S ribosomal protein L6 
(RPL6) 1.55 1.59   1.45   2 1.68 
Heterogeneous nuclear 
ribonucleoprotein H3 
(HNRNPH3) 1.71 1.49   1.79   1.88 1.37 
Nonmuscle myosin 
heavy chain / MYH9/11 
[overlap] 1.55 1.98 2.36 1.85 2.15 1.72 1.85 
Cullin-associated 
NEDD8-dissociated 
protein 1 (CAND1) 1.85 2.02 2.2 1.76 1.97 1.83 1.7 
Eukaryotic initiation 
factor 4A-II (EIF4A2) 1.89 2.02   1.71   1.93 1.84 
Similar to isoleucyl-tRNA 
synthetase (IARS)     2.42   2.2     
Fascin 1 (FSCN1) 1.84 1.92   1.72   1.9 1.68 
Similar to Tripeptidyl 
peptidase 2 (TPP2)     2.18   2.29     
Protein SET (SET) 1.62 2.01   1.69   1.82 1.93 
Similar to nuclear 
poly(C)-binding protein 1.83 2.18   1.74   1.74 1.8 
Filamin B (FLNB)     2.92   2.11     
DEAD-box RNA helicase 1.59 2.3   1.73   1.81 1.84 
Coatomer subunit alpha 
(COP1) 1.89 2.05 2.35 1.8 2.08 1.87 1.98 
Non-muscle myosin 
heavy chain IIa (MYH9) 1.4 1.84 2.36 2.12 2.12 1.65 1.97 
Heterogeneous nuclear 
ribonucleoprotein A3 
(HNRNPA3) 1.41 1.82   2.24   1.76 1.53 
Nonmuscle myosin 
heavy chain / MYH11 
[overlap] 1.5 1.88 2.05 1.94 2.03 1.69 1.7 
Vigilin (HDLBP)     1.87   2.16     
C-1-tetrahydrofolate 
synthase, cytoplasmic 
(MTHFD1) 1.5 1.93   1.79   1.57 1.25 
Heterogeneous nuclear 
ribonucleoprotein U 
(HNRNPU) 1.5 1.93 2.15 1.71 2.02 1.59 1.49 
Bifunctional aminoacyl-
tRNA synthetase (EPRS) 1.44 1.79 2.22 1.56 2.2 1.66 1.62 
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Alpha-centractin 
(ACTR1A) 1.83 1.73   2.07   1.97 2.18 
Heat shock protein 
70kDa (HSPA8) 1.58 1.94   2.06   1.84 2 
Alpha-actinin-4 (ACTN4) 1.68 1.91 2.51 2.19 2.95 1.79 1.84 
26S proteasome non-
ATPase regulatory 
subunit 1 (PSMD1) 1.74 2.02 2.24 1.93 2.54 1.9 1.84 
Gizzard PTB-associated 
splicing factor 1.86 1.97   2.31   1.88 1.89 
Exportin-1 (XPO1) 2 1.96 1.96 2.12 2.36 1.95 1.81 
Leucyl-tRNA synthetase 
(LARS) 2.07 2.09 2.47 2.02 2.34 1.85 1.79 
Heat shock 70 kDa 
protein 4 (HSPA4) 1.86 2 2.52 1.8 2.41 1.73 1.63 
Putative Alanyl-tRNA 
synthetase, cytoplasmic 
(ARS) 1.96 2.22 1.71 1.76 2.19 1.92 1.65 
Heat shock protein 4-like 
(HSPA4L) 1.95 2.05 1.26 1.76 2.41 1.78 1.44 
Clathrin heavy-chain 
(CHC) 1.62 1.74 3.21 2.06 2.28 1.56 1.59 
Actin, cytoplasmic 
(ACTG1) 2.14 1.54   1.52   1.61 1.54 
Hypoxia up-regulated 
protein 1 (HYOU1) 2.1 1.79 2.49 1.93 2.09 1.68 1.64 
Tubulin-specific 
chaperone D 2.13 1.89 2.66 2.17 2.17 1.41 1.48 
Ran GTP binding protein 
5 1.37 1.92 2.24 1.76 1.79 1.43 1.11 
Similar to Nucleoprotein 
TPR (TPR) 1.42 1.87 2.12 1.49 1.66 1.42 1.46 
Eukaryotic translation 
initiation factor 3 subunit 
A (EIF3A) 1.35 1.85 2 1.48 1.75 1.47 1.46 
116 kDa U5 small 
nuclear ribonucleoprotein 
component (EFTUD2) 1.46 1.87 2.48 1.6 2.12 1.45 1.49 
Exportin-2 (CSE1L) 1.48 1.82   1.55   1.47 1.34 
Nucleoporin 155 kPa 
(NUP155)     2.75   1.91     
Transketolase (TKT) 1.72 2.04   1.63   1.39 1.38 
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Similar to 
RanBP7/importin 7 
(IPO7) 1.48 1.85 2.3 1.42 2.07 1.47 1.27 
Ubiquitin carboxyl-
terminal hydrolase 7 
(USP7) 1.75 1.75 2.39 1.39 2.06 1.55 1.51 
Eukaryotic translation 
initiation factor 3 subunit 
B (EIF3B) 1.34 2 2.64 1.52 2.42 1.59 1.36 
L-lactate dehydrogenase 
B chain (LDHB) 1.45 1.14   1.28   1.77 1.87 
Heat shock protein 105 
(HSPH1) 1.64 1.95 1.98 2.2 2.14 1.51 0.75 
ATP-citrate lyase (ACLY) 1.88 1.99 1.95 1.69 1.93 1.46 0.9 
Poly [ADP-ribose] 
polymerase 1 (PARP1) 1.63 2 1.77 1.38 1.99 1.4 1.14 
Nuclear protein matrin 3 
(MATR3) 1.74 1.93 1.57 1.74 1.96 1.54 1.54 
Splicing factor 3B subunit 
1 (SF3B1) 1.55 1.94 1.8 1.9 1.61 1.42 1.81 
Heat shock cognate 
protein HSP 90-beta 
(HSP90AB1) 1.72 0.62   1.77   1.04 -0.51 
Serine/arginine repetitive 
matrix protein 1 (SRRM1)     0.77   1.87     
Fatty acid synthase 
Isoform 1 (FASN) 1.44 1.85 1.33 1.92 1.27 1.07 0.43 
Myosin heavy chain, 
Chick atrial myosin hevy 
chain, Cardiac muscle 
myosin, Skeletal myosin 
heavy chain [overlap] 0.81 1.8 3.49 3.46 5 3.26 3.84 
Similar to alpha-NAC, 
muscle-specific form 0.79 1.33 3.47 3.18 5.22 3.28 3.2 
Myosin-3, Skeletal 
myosin heavy chain 
[overlap] 1.25 1.65 2.97 3.17 4.27 3.16 3.3 
Alpha actinin-2 (ACTN-2) 1.39 1.74 2.82 2.94 4.4 2.84 3.38 
Myosin heavy chain, 
Chick atrial myosin heavy 
chain [overlap] 1.22 1.71 2.11 2.73 4.29 3.07 3.47 
Myosin-binding protein C, 
cardiac-type (MYBPC3) 1.74 1.81 2.46 3.08 3.99 3.21 3.65 
Chick atrial myosin heavy 
chain 1.37 1.8 2.7 2.89 4.19 3.32 3.78 
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Annexin A6 (ANXA6) 1.57 1.81   2.6   3.38 3.91 
Pan-muscle filamin 
isoform (CgABP260) 1.46 1.77 2.82 2.47 4.36 3.41 3.7 
Myosin heavy chain, 
Chick atrial myosin heavy 
chain, Myosin-3, Cardiac 
muscle myosin, Skeletal 
myosin heavy chain 
[overlap] 0.86 1.6 2.84 3.08 4.14 3.43 3.69 
Myosin heavy chain, 
Cardiac muscle myosin 
[overlap] 1.16 1.86 2.78 3.37 4.52 3.26 3.72 
Myosin heavy chain 1.27 1.95 2.34 3.32 4.66 3.34 3.81 
Smooth muscle gamma 
actin; alpha skeletal 
muscle; aortic smooth 
muscle; alpha cardiac 
muscle 1 [overlap] 1.73 1.79   4.01   4.32 4.47 
Myosin heavy chain, 
Chick atrial myosin heavy 
chain, Myosin-3, Skeletal 
myosin heavy chain 
[overlap] 1.54 2.09 2.44 3.49 4.09 3.68 4.1 
Xin actin-binding protein 
(XIRP1) 1.83 2.22 2.74 3.89 3.66 3.29 3.36 
 
Table 2-S1:Mass-Spec of early and late embryonic brain and heart tissue Heat map of all 
identified proteins from two experiments: E2, E4, and E10 Heart and Brain tissue normalized to 
E2 Brain, and HH3-5 embryonic disc and E3 heart and brain normalized to E3 Brain.  Proteins 
are clustered by the Manhattan Distance algorithm.  Grey cells indicate undetected proteins for 
that experiment.  The following is the heat-map key: 
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Chapter 3:  On the interplay between Cardiomyocytes and Collagen-secreting 
Cardiac Fibroblasts in the developing heart   
 
Requested Perspective:  Majkut SF, Dingal D, Discher DE. (2014) Current Biology:  Special issue 
on stress in development.  
 
Initial model development by Dave Dingal. 
 
3-1: Introduction 
Development of tissue with mechanical function could be based entirely on pre-programmed 
expression profiles, or perhaps there exist important feedback loops that involve sensing tissue 
mechanics.  Heart is the first organ to form, and recent studies document a stiffness that changes 
daily but matches the contractile optimum of the cardiomyocytes at each stage [60].  The 
dynamically evolving balance between cardiomyocyte contractile ability and matrix stiffness 
paralleled daily increases in the levels of excitation-contraction proteins and collagen-I relative to 
protein mass.  Cardiomyocytes express key excitation-contraction proteins but do not make 
matrix [61], while cardiac fibroblasts are distinctly specialized and secrete collagen-I and other 
matrix proteins but do not express muscle contractility proteins.  Thus this contraction-matrix 
balance must be met by a balance of cardiomyocyte and fibroblast populations (Fig. 3-1A).  Here 
we summarize current descriptions of fibroblast and cardiomyocyte population dynamics during 
development, and then a reasonably simple mathematical model is introduced to formally 
address how such a functional balance could be achieved between the two cell types during 
development.  Structural proteins in the nucleus called lamins also change dramatically in normal 
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development, and recent studies that revealed lamins to be mechanoresponsive and to directly 
regulate cytoskeleton expression motivate an extension of our first matrix-myosin model to the 
nuclear lamins.  The models presented may provide insight into some of the human genes most 
often linked to dilated cardiac myopathies, namely lamin-A and the myosin-II motors [62]. 
 
3-2: Cardiac fibroblast and collagen content during development: 
Cardiac fibroblasts (CF) are mesenchymal cells that arise primarily from the proepicardial region 
of the developing heart tube [63].  They are the primary extracellular matrix (ECM)-producing 
cells in the heart [61], but they also play significant roles in electrochemical and mechanical 
signaling in normal and injured developing and aging hearts [64].  In injuries such as infarcts in 
which cardiomyocytes die, CF’s rapidly proliferate and contribute to a collagen-rich scar at the 
site of injury, while adult cardiomyocytes do not proliferate but do grow in size (hypertrophy) 
seemingly in an effort to contract the scarred tissue [65, 66]. 
Until recently, quantifying the CF population has been difficult due to a lack of reliable markers 
[67].  Discoidin Domain Receptor 2 (DDR2), periostontin, cadherin-11 in combination with 
common fibroblast-associated proteins such as vimentin and fibronectin have recently been used 
as CF markers and have allowed for more precise studies of when and where CF arise in the 
heart and how this cell population develops [68, 69, 70, 71].  However, quantitative studies of 
cellular population by numbers or volume fraction in tissue have thus far focused on late-
embryonic to adult and aging hearts in various organisms [68, 72].  Relative fibroblast populations 
in adult hearts across species are typically attributed to requirements of increased collagen 
needed to withstand greater pressures in larger organisms, for example [73, 68, 74, 63].  
Similarly, increased collagen and fibroblast population are associated with periods of significant 
growth and postnatal developmental events that involve stiffening [75, 68, 76]Pathological 
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stiffening in response to disease or injury is also associated with increased collagen and local 
fibroblast population [77, 78, 79].   
There is limited information on cardiac fibroblasts in the early embryonic heart; however, collagen 
content across species and through development has been measured for decades [74]. Recent 
proteomic measurements of heart and brain during embryonic chick development show that this 
increase in matrix is matched by contractile proteins and parallel increased tissue mechanics 
(Fig. 3-1B).  By the time the heart tube first begins beating, the cellular make-up is thought to be 
fairly homogenous and primarily composed of early cardiomyocytes [80].  DDR2 is not expressed 
until well into embryonic development, so there is still no good marker for the earliest CFs.   
Therefore, how the cellular makeup from the early heart tube evolves to the make-up of adult 
tissue is not clear, but they must increase to relatively stable levels in adulthood.  (Fig. 3-1C).   
Several studies have demonstrated cultured cardiac fibroblast functional mechanosensitivity to a 
variety of stimuli.  Static or cyclic, uniaxial or biaxial strain has been shown to modulate ECM 
production by fibroblasts in a strain-dependent manner, with moderate strain inducing ECM 
production and large strain decreasing ECM production [81].  In vivo, such responses are likely 
complicated by mechanically stimulated paracrine signaling molecules that are also known to 
influence ECM production and proliferation rates of cardiac fibroblasts [82].   
3-3: Systems biology in cardiac physiology and development 
To address these the problem of how these complicated mechanical and chemical effects 
ultimately affect fibroblast proliferation and collagen deposition and the associated increase in 
contractile capacity of  the myocardium requires an integrative analysis of the known 
contribuatory factors.  Thus a systems biology approach in which the relevant gene message and 
protein dynamics are integrated into an appropriate model that captures  the relevant ECM and 
contractile protein behavior could prove extremely useful.   
 63 
 
Systems biology approaches in cardiac physiology and pathophysiology have the potential to 
help build an integrated understanding of the electrophysiological and physical processes 
involved in cardiac function [83, 84].  Eventually, models developed using systems biology could 
even allow for identification of therapeutic drug targets [85, 86].   
Fully understanding the details of how the balance of mechanical stiffness and contractile ability 
of myocardium is struck and changes with age and pathology ultimately requires a systems 
model that explicitly includes the various components of the developing heart ECM and 
cytoskeleton as well as any other functionally relevant signaling proteins integrated with a realistic 
physical model of the associated mechanics.   However, as myocardial stiffening is paralleled by 
primarily actomyosin contractility proteins and collagen I out of hundreds of the most abundant 
proteins proteins [87](Fig. 3-1B), we can initially consider a simplified system focusing on the 
interaction between the mechanical contribution of collagenous ECM deposited by cardiac 
fibroblasts and contractile cardiomyocytes.  Furthermore, a recent study simultaneously 
measuring the production and degradation of mRNAs and proteins in NIH3T3 mouse fibroblasts 
showed that the half-lives of are fairly constant within functional groups suggesting similar 
dynamics within groups [88].  Therefore we could further simplify this system to consider the 
Collagen-I as a representative of the matrix proteins and Myosin-II as a representative of the 
contractile-related proteins of the myocardium.   
Several studies have demonstrated functional mechanosensitivity of cultured cardiac fibroblast to 
a variety of stimuli.  Static or cyclic, uniaxial or biaxial strain has been shown to modulate ECM 
production by fibroblasts in a strain-dependent manner, with moderate strain inducing ECM 
production and large strain decreasing ECM production [81].  In vivo, such responses are likely 
complicated by mechanically stimulated paracrine signaling molecules that are also known to 
influence ECM production and proliferation rates of cardiac fibroblasts [82].   
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3-4: Model for Mechanical coupling between Collagen and Myosin production 
Since both static and cyclic strain encourage collagen production by cardiac fibroblasts, and both 
passive and active contraction increases in heart tissue through embryonic development, what is 
the mechanism that ultimately creates the balance between cardiac fibroblasts and 
cardiomyocytes?  As contractility, and therefore myosin expression must always effectively strain 
the heart tissue, we consider the case that fibroblast proliferation is ultimately limited by the 
stiffness or crowdedness of their environment.   
To explore possible general mechanisms, we considered a coupled rate equation between the 
relative concentrations of myosin and collagen mRNAs and proteins within developing cardiac 
and brain tissue.  We hypothesize that since collagen is produced primarily by cardiac fibroblasts, 
the rate of collagen mRNA production is proportional to the fibroblast population, which is limited 
by the stiffness, or crowdedness of their environment.  Since cardiomyocytes contain such high 
levels of contractile proteins, we consider them as the primary contributers of myosin in 
developing cardiac tissue.  We start with simple coupled rate equations for collagen and myosin 
mRNA and protein [89]: 
   
  
  ̃      
   
  
      ̃   
   
  
         
   
  
      ̃   
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Where Cp is collagen concentration, Cm is collagen mRNA concentration, Mp is myosin 
concentration,  Mm is myosin mRNA concentration, g and r are translation rate coefficients, and b 
and q are mRNA degradation  rate constants.  mRNA  production is proportional to protein level 
relative to cardiac cell concentration, with production rate coefficient j for myosin and  ̃ for 
collagen that is proportional to relative fibroblast proliferation rate.  As cardiac fibroblasts are 
embedded in the interstitial ECM between myocardial layers, we expect fibroblast proliferation to 
be limited by the density of this network in some way.  Confinement and stiffness in 2D culture 
has been demonstrated to affect fibroblast proliferation, and evidence is accumulating that 
fibroblasts from various origins cultured in 3D matrices proliferate less in stiffer environments [90].  
We therefore choose  ̃ proportional to a CF population constrained by collagen content to have 
the form 
 ̃   
  
 
  
    
  
where z is a Hill coefficient.  Protein degradation rates for collagen and myosin,   ̃ and  ̃, 
respectively are tension dependent coefficients of the form:   
  ̃   
  
    
      
    ̃   
  
    
      
   
Where     
 
  ⁄  and     
 
  ⁄  are affinity constants for collagen proteases and myosin heavy-
chain kinases that are proportional to stiffness contributions due to myosin contraction and 
collagenous matrix, respectively.  Thus the degradation terms of collagen and myosin are Hill-
type equations where the typical association-dissociation constant is proportional to K, a power of 
tension applied by active myosin contraction in the case of collagen, or to k, in response to ECM 
mechanics in the case of myosin.  Collagen matrices have been shown to be stabilized from 
degradation by applied tension [91, 92] and myosin-IIs under tension can be preferentially un-
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phosphorylated leading to increased incorporation into stress-fibers [93].  The mechanism for 
tension-stabilization for these polymers is not known, but Swift et al. (2013) argue that tension 
may cause changes of the network or polymers itself that sterically or conformationally prevent 
direct protease binding, in the case of collagen, or kinase binding that leads to dissociation and 
digestion, in the case of polymeric myosins [89].  The universality of stress stabilization against 
degradation by all proteases is not yet clear, and some evidence to the contrary exists from 
single-molecule studies of collagen [94].  However such studies are not inconsistent with the idea 
that a stressed network could be stabilized against degradation as proposed because, whereas in 
single molecule studies, the fibers could unwind, networked polymers under stress typically could 
not and stress may therefore lead to further tightening of coils and knots.  Table 1. gives all 
parameters used.  All linear coefficients, namely a, b, g, h, j, q, r, and s are of order ~1 for both 
the heart indicating that protein and mRNA production and degradation are occurring on similar 
scales.  In the case of the brain, the myosin protein production rate j is decreased relative  to that 
of the heart giving the decreasing myosin trends over time and lower final collagen levels.   
By extending simple coupled regulatory gene network to include mechanically regulated protein 
degradation and constrained fibroblast proliferation, we can qualitatively reconstitute our 
measurements of relative myosin and collagen content in the developing heart (model results in 
Fig. 3-2 compared to measurements in Fig. 3-1B).  In particular, collagen and myosin increase 
over days to reach stable steady-state values in the heart.  By decreasing the rate of myosing 
production in brain, r, the brain myosin decreases to a steady low value while the collagen level 
increases only slightly to a value lower than the heart.  This model is underconstrained by data, 
but it opens the door to avenues of inquiry that are important to address.  For instance, growing 
evidence of biopolymer networks stabilized by tension suggests that this may be a generalizable 
biological phenomenon.  The functional form may be complicated by e.g. mechanosensitive 
modulation of proteolytic enzymes or the polymer itself, but the Hill-type equation we propose 
here seems a sensible place to start.   
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3-5: From ECM to the nucleus 
So far, we have considered the interplay between extracellular matrix mechanics and cellular 
contractile capacity.  Implicit in this interplay is communication of extracellular and intracellular 
mechanics with the translational machinery of the nucleus.  Mechanosensitivity at the cell-ECM or 
cell-cell interface has been shown to contribute to biochemical signaling pathways that lead to 
changes in activity in the nucleus [95].  But mechanical signals from the extracellular environment 
can also be transmitted physically by the contractile cytoskeleton to the nucleus via connections 
through the nuclear membrane to the nuclear lamina [96].  The nuclear lamina is composed of a 
meshwork of filamentous proteins that confer mechanical stability to the nucleus and interact with 
chromatin and various proteins that regulate transcription.  These proteins, Lamins, constitute a 
group of class V intermediate filaments found in all metazoans.  In vertebrates, typically two types 
of Lamins, A and B, are expressed in tissue-specific ratios, with at least one Lamin B-type protein 
expressed ubiquitously.  Of particular interest here, Swift et al. recently found that Lamin A:Lamin 
B ratio in adult tissues scales with tissue stiffness, and also enhances mechanically directed 
differentiation [89].  Thus not only do cardiomyocyte contractility and extracellular matrix during 
development feedback into each other, nuclear lamina structure and composition is in turn 
involved with this mechanical coupling.   
3-6: Lamins in development  
Lamin expression has been shown to be both developmentally regulated and to play a role in 
tissue-specific maturation and differentiation.  Developmental studies in mice [97], xenopus [98] 
and chickens [99] show that Lamin A is typically expressed first in muscle and not until late 
embryogenesis or shortly after birth, and continues to increase into adulthood.  Quantitative 
measurements by Lehner et al (1987) in developing chick embryos demonstrated differential 
expression of Lamin B2, B1 and A in various tissues (Fig. 3-3, data from [99]).  As far as we 
know, these are the only such measurements throughout early embryonic development in 
chickens.  Lamin B2 was constitutively expressed at stable levels, but Lamin B1 and Lamin A 
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were variably expressed in tissues through time.  Fig. 3-3 presents Lamin levels in heart and 
brain during chick development [99].  In brain, the total Lamin A and B1 normalized by Lamin B2 
remained relatively constant (Fig. 3-3A).  This total amount is dominated by Lamin B1 throughout 
the development and aging. Although the ratio of Lamin A to Lamin B2 was negligible before E10, 
it then increases to a non-negligible level into adulthood.  In heart, measurements were not made 
during early embryogenesis.  However, by late embryogenesis and into adulthood, Lamin A is the 
major variable isoform and constitutes much more of the heart cell nuclear lamina than in the 
brain.   
3-7: Lamin A in cardiac development and disease 
In a general review of genetic mechanisms underlying dilated cardiac myopathy (DCM), 
mutations in the LMNA, the gene responsible for Lamin A/C, were identified among a list of the 
most common mutations associated with DCM and conduction system disorders [62].  A genetic 
study of families with autosomal dominant DCM and conduction-system disease have been 
shown to be caused by Lamin A/C defects in the coiled rod-domain and c-terminal domain [100].  
How these mutations and defective Lamin expression results in impaired cardiac contraction and 
conduction is intimately related to the roles different types of Lamins play in healthy tissue 
development and adult function.  LMNA gene defects account for 33% of DCM with 
atrioventricular block, a common conduction disorder [101].  In a later broader study of unrelated 
patients with DCM, LMNA mutations occurred in 6% of patients [102].  In these studies, no or mild 
serum creatine-phosphatase were measured, which is typically associated with muscular 
dystrophies or general muscle tissue damage.  Instead, they saw damaged myocyte nuclei, which 
they hypothesize could lead to myocyte death and that accumulates over time, leading to DCM 
and conduction-disease phenotypes [101].  This type of cell death and tissue malfunction could 
also be caused by mislocalization of associated muscle specific genes [103] due to altered 
nuclear mechanics.  In addition, altered lamin-A/C assembly and interaction with another nuclear 
protein, emerin, could lead to defective  regulation of nuclear actin.  This in turn would affect 
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nuclear-cytoplasmic shuttling of MKL1, a critical transcription factor to cardiac development and 
function [104] .  Thus proper Lamin-A expression in developing and mature cardiac tissue is 
critical to tissue maintenance from a structural to transcriptional level.   
 
3-8: Model of Lamin levels in response to Myosin:  
We propose a model of coupled myosin and Lamin-A expression in cardiomyocytes much like the 
coupled myosin-collagen model.  Here we start with simple regulatory equations and include 
tension-stabilized degradation of both Lamin and Myosin proteins, as before.   
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Where                 are rate constants and  ̃ and  ̃ are tension-stabilizing degradation 
coefficients 
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Once again     
 
  ⁄  and   are affinity constants for lamin kinases and myosin heavy-chain 
kinases that are proportional to stiffness contributions due to myosin contraction and collagenous 
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matrix, respectively.  Table 2. gives all parameters used.  Unlike the myosin-collagen model, the 
lamin and myosin are produced by the same cell, so relative cell concentrations do not need to be 
taken into account.  Like myosins, Lamins are thought to dissociate from their meshwork and get 
degraded when phosphorylated, but whether stress influences phosphorylation and degradation 
is understudied.  We consider the steady-state solutions as a function of explicitly input k (Fig. 3-
4).  Steady-state Lamin A and myosin protein levels, Lss and Mss, respectively, follows a linear 
relation with explicit k input.  Here we use the relation between relative Lamin A levels and tissue 
stiffness reported by Swift et al. (2013) [89], Lss ~ E
0.7
 to infer a relation Lss ~ k3.15 ~ E3.15*y, k ~ 
E
0.22
.  This in turn gives the relation between myosin levels and matrix stiffness Mss ~ E
0.46
.  
Ultimately, with more measurements of Lamin levels in developing chick tissue, this type of 
coupled modeling could be extended to include coupling of ECM to cytoskeleton to nucleus.   
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Figure 3-1: Cardiomyocyte and Fibroblasts create a balance between contractile ability 
and ECM abundance during development (A)  Schema illustrating concept of how such a 
balance could be struck.  Early in development, cardiomyocytes are relatively small with 
unorganized and relatively spare myofibril content.  Cardiac fibroblasts feel strain from passive 
and active contraction of surrounding cells (orange arrows) propagated through the ECM and 
cell-cell adhesions (yellow arrows) prompting them to divide and produce ECM in a strain and 
growth-factor responsive manner.  The increased ECM due to increased CF population prompts 
increased production of myofibril proteins and encourages myofibril organization, which in turn 
increases contractile strain on the cardiac fibroblasts. We propose that fibroblast population 
growth is at least in part limited by stiffness and confinement, leading to an ultimate steady state 
of CM to FB volume fractions in normal adult tissue.  (B)  Tissue stiffness of embryonic chick 
heart and brain tissue was measured to increase throughout embryonic development in a way 
that is paralleled with both collagen-I and cardiac Myosin-II expression.  (C) Half-lives of 
collagens (dark blue) and collagen-binding integrins (light blue), actomyosin contractility (red), 
and nuclear Lamin mRNAs and proteins measured coincidently in NIH3T3 mouse fibroblasts.  
Half-lives of are fairly constant within functional groups suggesting similar dynamics within 
groups.   
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Figure 3-2: Model Collagen-I and Myosin mRNA and Protein expression during 
development Results from our coupled models of tissue-level concentrations of cardiac myosin 
II, primarily located within cardiomyocytes, and collagen-I, located extracellularly and produced 
primarily by cardiac fibroblasts, qualitatively recapitulate the trends we see in developing heart (A) 
and brain (B) tissue. 
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Figure 3-3: Lamin levels in heart and brain during development (adapted from Lehner et al. 
1987).  (A) Total variable Lamins A and B1 normalized by constant Lamin B2 in brain (blue) and 
heart (red).  In brain , this total remained relatively constant; in heart, this total increases from late 
embryogenesis to adult levels.  (B) This total amount is dominated by lamin B1 throughout the 
development and aging, although while the ratio of Lamin A was negligible before E10, it then 
increases to a non-negligible level adulthood, while it .  In heart, measurements are more sparse 
and missing during early embryogenesis.  However, by late embryogenesis and into adulthood, 
Lamin A is the major variable isoform and constitutes much more of the heart cell nuclear lamina 
than in the brain.   
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Figure 3-4: Steady-state Lamin and Myosin levels given matrix elasticity Steady-state Lamin 
A and myosin protein levels given explicit k input.  Here we use the relation between relative 
Lamin A levels and tissue stiffness reported by Swift et al. (2013) [89],  Lss ~ E0.7 to infer a 
relation between k ~ E0.45.  
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Table 3-1:Rate constants and coupling constants for Collagen-myosin coupled model 
 
  
Constant Heart Brain
Rate constants
a 6.2 6.2
b 5 5
g 3 3
h 6 6
j 4.1 4.1
q 3 3
r 1.3 0.005
s 4 4
Coupling constants
z 0.99 0.99
a0 0.9 0.9
A1 1.4 1.4
A2 3 3
Initial conditions
Cm(0) 0.0006 0.0006
Cp(0) 0.0006 0.0006
Mm(0) 0.07 0.07
Mp(0) 0.07 0.07
 76 
 
 
Table 3-2:Rate constants and coupling constants for Lamin-myosin coupled model 
 
 
 
 
 
 
 
  
Constant
Rate constants
a 1
b 2
g 3
h 4
j 3
q 2
r 1
s 4
Coupling constants
z 3
A1 3
A2 3
Initial conditions
Lm(0) 0.0006
Lp(0) 0.0006
Mm(0) 0.07
Mp(0) 0.07
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CHAPTER 4: Method to visualize and study embryonic cardiomyocyte nuclei and 
Lamins in vitro and in vivo. 
4-1: Introduction 
The previous chapter argues that the nuclear lamina is influential in the mechanical regulation of 
cardiomyocyte function.  Here we outline a method to image and manipulate the nuclear lamina 
of live beating embryonic cardiomyocytes in tissue and in culture.   
4-2: Methods 
Chick culture and heart extraction 
Fertilized White Horn chicken premium eggs (Charles Rivers Labswere incubated at 37˚C in a 
humid incubator with low CO2 with broad end up and rotated 180˚ once each day until the desired 
embryonic stage is reached.  To extract E4 HTs, eggs are windowed on the broad end to expose 
the embryo, overlying membranes are removed, and the embryo is released from the 
extraembryonic tissue with fine forceps and gently lifted out of the egg and placed in room 
temperature PBS.  The HT is  
Whole tissue transfection 
Lipofectamine/plasmid complexes were prepared as prescribed by the manufacturers 
(Lipofectamine 2000, Invitrogen) and illustrated in Fig. 4-2A.  For a single well of a 12-well dish, 
15 micrograms of plasmid  GFP-Lamin-A and 10 μL Lipofectamine were each diluted to total 
volumes of 50 μL in Opti-MEM (Gibco, 31985-070) and stayed at room temperature for 5 min 
before combining both solutions to make the final transfection solution which again sat at room 
temperature for an additional 25 min.  2-4 HTs per well were preincubated in 0.5 mL pre-warmed 
chick heart media during lipofectamine/plasmid complex formation.  The lipofectamine/plasmid 
complex was added to the heart tubes in heart media and left to incubate at 37˚C 5% CO2 for 12-
18 hours.  Transfection media was replaced with prewarmed chick heart media and the heart 
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tubes continued incubating until use in stiffening or softening experiments and subsequent 
imaging.   
Cell isolation and culture on elastic substrates 
We isolated cells from heart tissue by dicing to sub-millimeter size and then digesting with 
Trypsin/EDTA (Gibco, 25200-072).  We incubated tissue in approximately 1 mL Trypsin per E4 
HT in a 15 mL conical tube  for 13 min rotating on its side at 37˚C, then for 2 min upright to let 
large tissue pieces settle before carefully removing supernatant which should contain blood cells, 
being cardful not to disturb the settled tissue.   We replacing with an equal volume of fresh 
Trypsin, and finally shaking for 15 more min.  We stop digestion by adding an equal volume of 
chick heart media and release the cells from the tissue by pipetting up and down slowly (~2 mL/s) 
with a 5 mL glass pipette 5-8 times.  Large pieces were then allowed to settle and the 
supernatant is plated on  prepared Pa gels.   Cells were plated at concentrations of approximately 
2x10^5 cells/cm directly on collagen I coated PA gels of varying stiffness as described in Chapter 
3.  
Imaging and analysis of cellular and nuclear strain 
Cardiomyocytes beating on PA gels were imaged after 24 hours in culture.  Hoechst staining 
(1:1000, 33342 Sigma)  on some non-transfected samples was performed for 10 minutes at room 
temperature, followed by 3x rinse with heart media to visualize nuclei, but they quickly stopped 
beating upon fluorescent imaging.  Cells were imaged on an Olympus 1x81 microscope and 
recorded with a ccd camera with fluorescent and phase-contrast filters.  Phase-contrast movies 
(23 fps) of beating cardiomyocytes with Hoescht-stained or GFP-Lamin A positive nuclei, as well 
as fluorescent movies of the nuclei (17 fps) were segmented using a Matlab program as 
described in Chapter 3 and the cell aspect ratio (AR) was tracked over time.  (ARrelaxed – 
ARcontracted)/ARrelaxed  was calculated as a measure of cell and nuclear strain for at least 4 beats for 
each cell.   
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4-3: Results and Discussion 
E4 cardiomyocyte contraction significantly deforms the nucleus (Fig. 4-1A).  Live-cell imaging of 
Hoescht-stained nuclei in beating cardiomyocytes on 1 kPa PA gels shows significant 
deformation of both cell and nucleus (Fig. 4-1B). 
Whole heart transfections with GFP-Lamin A (Fig. 4-2A) results in sparse cell transfections such 
that number of cells transfected increases in a dose-dependent manner with plasmid 
concentration (Fig.4- 2B).  This allows for imaging of transfected nuclei in intact beating tissue, 
which could then be manipulated as described previously, e.g. collagenase or transglutaminase 
softening or stiffening of   the collagenous ECM.   
We isolated cells from transfected heart tubes and cultured them on collagen-coated PA gels of 
1, 10, and 34 kPa for 24 hours.  It should be noted that although although measurements of 
relative Lamin expression in the literature is missing at this early developmental stage, we can 
extrapolate from Fig 4-3 that it is low.  Therefore transfected cells are necessarily perturbed both 
in that Lamin A transfection should stiffen the nucleus and possibly feed into increased myosin 
expression.  12-18 hours transfection and 24 hours in culture gives significant time for changes in 
gene expression in response to the transfection.    
Preliminary results for nuclear deformation relative to cellular deformation for cells on gels agree 
with our naïve expectations for cells on rigid to very soft substrates (Fig. 4-3).  Cells on rigid 
substrates (e.g. glass) should not be able to contract the substrate, and therefore should have not 
edge deformation.  However, cardiomyocytes have been shown to beat on glass, so the nucleus 
should still respond to intracellular stresses.  We find that for well-beating cells, cell strain and 
nuclear strain both increase with decreasing substrate stiffness.  For cells that are appear to beat 
very weakly, the nucleus also deforms very little.   As the substrate softens and approaches the 
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optimum described in chapter 3, the cell should be able to deform its substrate more and more, 
and increasingly strain the nucleus.  Finally as the substrate becomes too soft and the contractile 
cytoskeleton becomes less organized and loses contractile capacity, the cardiomyocyte strains its 
substrate less because its intracellular stress is less, which would be reflected in the nuclear 
deformation.   Similarly, cells that beat uncharacteristically little on the 1 and 10 kPa gels here 
could be unhealthy or malfunctioning in some way and that is reflected in the lack of nuclear 
strain indicating that those cells just are not contracting well.  This is in contrast to the cells on stiff 
substrates that  to show similar cell edge strain, but significant nuclear strain, indicating that the 
contractile ability of the cells are incapable of deforming the substrate well, but still very 
functional.  Therefore the nucleus serves as a useful indicator for cardiomyocyte contractile 
activity.   
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Figure 4-1: . Contractile beating of embryonic cardiomyocytes on elastic substrates.  (A) 
Hoescht-stained nucleii of beating cardiomyocytes show nuclear strain during contraction.  (B) 
Aspect ratio of nucleus and cell over time shows significant deformation of during contraction.   
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Figure 4-2: Sparse transfection of embryonic heart tubes for perturbation and imaging of 
nuclear Lamins.  (A) Method for transfection of whole heart and isolation of cells for imaging.  
(B)Whole E4 HT transfected with GFP-Lamin-A at low and high resolution (inset).  (C)  Relaxed 
and contracted E4 cardiomyocyte and GFP-Lamin-A transfected nuclei on collagen-coated PA 
gels 
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Figure 4-3: Nuclear deformation vs. cellular deformation.  Nuclear fractional change in aspect 
ratio is plotted relative to cellular fractional change in aspect ratio.  Expected behavior is 
illustrated in the inset. Cell strain and nuclear strain both increase with decreasing substrate 
stiffness.  For cells that are appear to beat very weakly, the nucleus also deforms very little, 
indicating much smaller intracellular strain. 
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CHAPTER 5: Conclusions and future directions 
 
Conclusions: 
In conclusion, this work attempts to characterize the dynamic mechanics of early heart 
development and the structural and molecular contributers and responses to those mechanics.  
We find that heart tissue stiffens during development, in contrast to brain which remains soft. 
These mechanical trends are paralleled by abundant cytoskeletal and ECM network proteins, in 
particular the contractile actomyosin cytoskeleton and Collagen-I, respectively. Disrupting these 
proteins decrease effective E
tissue
.  Both in intact tissue and isolated on elastic substrates, 
cardiomyocytes strain most on environments of physiological stiffness.  Myofibril striation also 
optimized on intermediate stiffnesses.  Unlike the optimized strain, contraction wave speed of 
intact myocardium goes proportionally with tissue stiffness, consistent with new theory presented 
here. The trends of myosin and collagen protein expression in developing tissues over timecan 
be reconstituted with a coupled model including stress-stabilized degradation and extended to 
Lamin-Myosin interactions.  Finally, as the nuclear Lamina is intimately linked with and can be 
strained by the contractile cytoskeleton of the cell, imaging the nucleus in intact tissue could 
prove a useful read-out to intercellular strain.  We finish by presenting a useful and novel method 
of sparse fluorescent plasmid transfection in live intact embryonic cardiac tissue.   
 
Future Directions: 
Chapter 2:  The micropipette aspiration measurements of tissue stiffness were based on highly 
simplified models of tissue as an elastic half-space.  More detailed or realistic models are 
currently being developed and could allow us to better understand the mechanics of the 
developing tissues in heart as well as viscous brain and embryo.  Aside from giving a more 
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accurate measure of stiffness, a more detailed and realistic model that takes into account viscous 
properties of cells and ECM. One major advantage of micropipette aspiration is the dynamical 
strain information that it can provide, which our simplified model does not capture. Another very 
interesting and under-explored aspect of this research is the implications of the contraction wave 
model.   
 
 
Chapter 3: The models of Chapter 3 point to a broad array of possible experimental and modeling 
avenues of inquiry.  In particular, Lamin A, B1, and B2 levels could be more precisely and 
accurately measured throughout chick cardiogenesis using quantitative western immunoblotting.  
Absolute myosin, collagen, and Lamin A protein and mRNA expression could be quantified 
throughout development to get better estimates for some of the parameters of the models.  The 
concept of strain-stabilized biopolymer networks is understudied, particularly in the case of 
Lamins.  Finally, chapter 4 argues that matrix, cytoskeleton, and nuclear lamina are all intimately 
coupled, so the two models presented here should be further integrated to include all three 
structural proteins.   
 
 
Chapter4: As discussed in Chapter 4, with the technique of sparse transfection of intact tissue 
with various gfp-Lamin A constructs, we are well positioned to study the effects of over-
expression or under- or defective expression of Lamin A on nuclear mechanics.  The Discher lab 
has used various LaminA phospho-mimetic and disease related mutants that disrupt Lamin A 
assembly but still localize in the nucleus, thus acting as dominant-negative constructs in 
transfected cells. Of particular, a R453W mutant is a common mutant in Emory Dreyfuss 
Muscular Distrophy, a form of the disease associated with the most common laminopathy-related 
cardiac defects, in particular DCM and conduction defects.  Nucleii of cells transfected with GFP-
WT Lamin A and GFP-mutant Lamin A  could therefore be imaged and measured in intact 
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beating tissue, aspirated cells and tissue, and isolated cardiomyocytes on collagen-coated PA 
gels of various stiffnesses.  Changes in nuclear mechanics could be measured in isolated cells 
and in tissue using micropipette aspiration.  Nuclear morphology and strains could be correlated 
to tissue, cytoplasmic, and matrix strains during beating.   
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